RxNorm Semantic Concepts Index - 268
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "268".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 2680119 | Calmera | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2680120 | clomipramine hydrochloride 20 MG [Calmera] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2680120 | clomipramine hydrochloride 20 MG [Calmera] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2680121 | Calmera Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2680122 | Calmera Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2680123 | clomipramine Oral Tablet [Calmera] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2680123 | clomipramine Oral Tablet [Calmera] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2680124 | clomipramine hydrochloride Oral Tablet [Calmera] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2680125 | CALMERA 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2680125 | CALMERA 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2680125 | CALMERA 20 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2680125 | CALMERA 20 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2680126 | clomipramine hydrochloride 40 MG [Calmera] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2680126 | clomipramine hydrochloride 40 MG [Calmera] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2680127 | CALMERA 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2680127 | CALMERA 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2680127 | CALMERA 40 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2680127 | CALMERA 40 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2680128 | clomipramine hydrochloride 5 MG [Calmera] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2680128 | clomipramine hydrochloride 5 MG [Calmera] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2680129 | CALMERA 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2680129 | CALMERA 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2680129 | CALMERA 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2680129 | CALMERA 5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2680130 | clomipramine hydrochloride 80 MG [Calmera] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2680130 | clomipramine hydrochloride 80 MG [Calmera] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2680131 | CALMERA 80 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2680131 | CALMERA 80 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2680131 | CALMERA 80 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2680131 | CALMERA 80 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2680132 | Dictamnus albus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2680133 | alpelisib Granule Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2680134 | alpelisib Oral Granules | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2680135 | alpelisib 50 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680135 | alpelisib 50 MG Oral Granules | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2680135 | alpelisib 50 MG Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680136 | Vijoice Granule Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2680137 | alpelisib Oral Granules [Vijoice] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2680138 | Vijoice 50 MG Oral Granules | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2680138 | Vijoice 50 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680138 | Vijoice 50 MG Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680139 | alpelisib 50 MG Oral Granules 28 Day Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2680139 | alpelisib 50 MG Oral Granules 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680139 | alpelisib 50 MG Oral Granules 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680140 | Vijoice 50 MG Oral Granules 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2680140 | Vijoice 50 MG Oral Granules 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680140 | Vijoice 50 MG Oral Granules 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680277 | asciminib 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2680278 | asciminib 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680278 | asciminib 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680278 | asciminib 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2680279 | asciminib 100 MG [Scemblix] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2680280 | SCEMBLIX 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2680280 | SCEMBLIX 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680280 | SCEMBLIX 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680280 | SCEMBLIX 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680283 | tocilizumab-bavi | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2680284 | tocilizumab-bavi 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2680287 | tocilizumab-bavi 200 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2680287 | tocilizumab-bavi 200 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680287 | tocilizumab-bavi 200 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680288 | tocilizumab-bavi 20 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2680289 | Tofidence | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2680290 | tocilizumab-bavi 20 MG/ML [Tofidence] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2680291 | Tofidence Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2680292 | tocilizumab Injection [Tofidence] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2680294 | Tofidence 200 MG in 10 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2680294 | Tofidence 200 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680294 | Tofidence 200 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680294 | Tofidence 200 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680295 | tocilizumab-bavi 20 MG/ML Injection [Tofidence] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2680295 | tocilizumab-bavi 20 MG/ML Injection [Tofidence] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2680296 | tocilizumab-bavi 400 MG in 20 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2680296 | tocilizumab-bavi 400 MG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680296 | tocilizumab-bavi 400 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680297 | Tofidence 400 MG in 20 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2680297 | Tofidence 400 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680297 | Tofidence 400 MG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680297 | Tofidence 400 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680298 | tocilizumab-bavi 80 MG in 4 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2680298 | tocilizumab-bavi 80 MG in 4 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680298 | tocilizumab-bavi 80 MG in 4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680299 | Tofidence 80 MG in 4 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2680299 | Tofidence 80 MG in 4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680299 | Tofidence 80 MG in 4 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680299 | Tofidence 80 MG in 4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680300 | acetaminophen 650 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2680300 | acetaminophen 650 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2680300 | acetaminophen 650 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680300 | acetaminophen 650 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680300 | acetaminophen 650 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2680300 | acetaminophen 650 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680300 | acetaminophen 650 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2680301 | glyceryl 2-caprylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2680302 | iloprost Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2680303 | iloprost 100 MCG in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2680303 | iloprost 100 MCG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680303 | iloprost 100 MCG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680304 | iloprost 0.1 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2680305 | Aurlumyn | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2680306 | iloprost 0.1 MG/ML [Aurlumyn] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2680307 | Aurlumyn Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2680308 | iloprost Injection [Aurlumyn] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2680309 | Aurlumyn 100 MCG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680309 | Aurlumyn 100 MCG in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2680309 | Aurlumyn 100 MCG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680309 | Aurlumyn 100 MCG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680310 | iloprost 0.1 MG/ML Injection [Aurlumyn] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2680310 | iloprost 0.1 MG/ML Injection [Aurlumyn] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2680311 | oleamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2680313 | Amlodipine (as amlodipine maleate) 5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2680313 | Amlodipine (as amlodipine maleate) 5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2680315 | Amlodipine (as amlodipine mesilate) 5 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2680315 | Amlodipine (as amlodipine mesilate) 5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2680315 | Amlodipine (as amlodipine mesilate) 5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2680317 | Gentiana manshurica root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2680319 | lidocaine 4 % / menthol 0.7 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2680319 | lidocaine 4 % / menthol 0.7 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2680319 | lidocaine 4 % / menthol 0.7 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2680322 | naphazoline hydrochloride 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2680323 | naphazoline hydrochloride 1 % Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2680323 | naphazoline hydrochloride 1 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2680323 | naphazoline hydrochloride 1 % Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2680356 | salicylic acid 70 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2680357 | salicylic acid 7 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2680357 | salicylic acid 7 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2680357 | salicylic acid 7 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2680359 | nirogacestat 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2680360 | nirogacestat 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680360 | nirogacestat 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680360 | nirogacestat 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2680361 | nirogacestat 100 MG [Ogsiveo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2680362 | Ogsiveo 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2680362 | Ogsiveo 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680362 | Ogsiveo 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680362 | Ogsiveo 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680363 | nirogacestat 100 MG Tablet 7-Day 14 Count Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2680363 | nirogacestat 100 MG Tablet 7-Day 14 Count Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680363 | nirogacestat 100 MG Tablet 7-Day 14 Count Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680364 | Ogsiveo 100 MG Tablet 7-Day 14 Count Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2680364 | Ogsiveo 100 MG Tablet 7-Day 14 Count Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680364 | Ogsiveo 100 MG Tablet 7-Day 14 Count Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680365 | nirogacestat 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2680366 | nirogacestat 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680366 | nirogacestat 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680366 | nirogacestat 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2680367 | nirogacestat 150 MG [Ogsiveo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2680368 | Ogsiveo 150 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2680368 | Ogsiveo 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680368 | Ogsiveo 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680368 | Ogsiveo 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680369 | nirogacestat 150 MG Tablet 7-Day 14 Count Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2680369 | nirogacestat 150 MG Tablet 7-Day 14 Count Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680369 | nirogacestat 150 MG Tablet 7-Day 14 Count Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680370 | Ogsiveo 150 MG Tablet 7-Day 14 Count Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2680370 | Ogsiveo 150 MG Tablet 7-Day 14 Count Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680370 | Ogsiveo 150 MG Tablet 7-Day 14 Count Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680384 | Imidamine sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2680384 | Imidamine sulfate | Designated preferred name (PT) | NO | |
| RxCUI: 2680384 | Imidamine sulfate | Full form of descriptor (FN) | NO | |
| RxCUI: 2680384 | Imidamine sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2680384 | Imidamine sulfate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2680384 | Imidamine sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2680384 | Imidamine sulfate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2680384 | Imidamine sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2680385 | Atosiban acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2680385 | Atosiban acetate | Designated preferred name (PT) | NO | |
| RxCUI: 2680385 | Atosiban acetate | Full form of descriptor (FN) | NO | |
| RxCUI: 2680386 | Betamethasone sodium phosphate 1 mg/g and neomycin sulfate 5 mg/g eye ointment | Designated preferred name (PT) | NO | |
| RxCUI: 2680386 | Betamethasone sodium phosphate 1 mg/g and neomycin sulfate 5 mg/g eye ointment | Full form of descriptor (FN) | NO | |
| RxCUI: 2680581 | pradofloxacin trihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2680713 | pradofloxacin 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2680714 | pradofloxacin Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2680715 | pradofloxacin Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2680716 | pradofloxacin 200 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2680716 | pradofloxacin 200 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2680716 | pradofloxacin 200 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2680717 | Pradalex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2680718 | pradofloxacin 200 MG/ML [Pradalex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2680719 | Pradalex Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2680720 | pradofloxacin Injectable Solution [Pradalex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2680721 | Pradalex 200 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2680721 | Pradalex 200 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2680721 | Pradalex 200 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2680723 | lidocaine 0.0488 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2680724 | lidocaine 4.88 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2680724 | lidocaine 4.88 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680724 | lidocaine 4.88 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680726 | mirikizumab Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2680728 | mirikizumab-mrkz 100 MG in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2680728 | mirikizumab-mrkz 100 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680728 | mirikizumab-mrkz 100 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680729 | mirikizumab-mrkz 100 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2680729 | mirikizumab-mrkz 100 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2680729 | mirikizumab-mrkz 100 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2680730 | mirikizumab Prefilled Syringe [Omvoh] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2680732 | omvoh 100 MG in 1 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2680732 | omvoh 100 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680732 | omvoh 100 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680733 | omvoh 100 MG/ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2680733 | omvoh 100 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2680733 | omvoh 100 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2680735 | Rextovy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2680736 | naloxone hydrochloride 16 MG/ML [Rextovy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2680737 | Rextovy Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2680738 | Rextovy Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2680739 | naloxone Nasal Spray [Rextovy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2680741 | REXTOVY 4 MG in 0.25 ML Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2680741 | REXTOVY 4 MG in 0.25 ML Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680741 | REXTOVY 4 MG in 0.25 ML Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680742 | adalimumab-adbm 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2680743 | adalimumab-adbm 40 MG per 0.4 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2680743 | adalimumab-adbm 40 MG per 0.4 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680743 | adalimumab-adbm 40 MG per 0.4 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680744 | adalimumab-adbm 100 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2680744 | adalimumab-adbm 100 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2680744 | adalimumab-adbm 100 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2680745 | adalimumab-adbm 100 MG/ML [Cyltezo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2680746 | CYLTEZO 40 MG in 0.4 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2680746 | CYLTEZO 40 MG in 0.4 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680746 | CYLTEZO 40 MG in 0.4 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680747 | CYLTEZO 100 MG/ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2680747 | CYLTEZO 100 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2680747 | CYLTEZO 100 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2680748 | adalimumab-adbm 40 MG in 0.4 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2680748 | adalimumab-adbm 40 MG in 0.4 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680748 | adalimumab-adbm 40 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680749 | adalimumab-adbm 100 MG/ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2680749 | adalimumab-adbm 100 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2680749 | adalimumab-adbm 100 MG/ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2680750 | CYLTEZO 40 MG in 0.4 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2680750 | CYLTEZO 40 MG in 0.4 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680750 | CYLTEZO 40 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680751 | CYLTEZO 100 MG/ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2680751 | CYLTEZO 100 MG/ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2680751 | CYLTEZO 100 MG/ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2680756 | adalimumab-adbm Pen 40 MG/0.4 ML Starter Pack - Psoriasis/Uveitis (4 count) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2680756 | adalimumab-adbm Pen 40 MG/0.4 ML Starter Pack - Psoriasis/Uveitis (4 count) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680756 | adalimumab-adbm Pen 40 MG/0.4 ML Starter Pack - Psoriasis/Uveitis (4 count) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680757 | CYLTEZO Pen 40 MG/0.4 ML Starter Pack - Psoriasis/Uveitis (4 count) | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2680757 | CYLTEZO Pen 40 MG/0.4 ML Starter Pack - Psoriasis/Uveitis (4 count) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680757 | CYLTEZO Pen 40 MG/0.4 ML Starter Pack - Psoriasis/Uveitis (4 count) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680759 | adalimumab-adbm Pen 40 MG/0.4 ML - Starter Pack for Crohn's Disease, Ulcerative Colitis or Hidradenitis Suppurativa (6 count) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2680759 | adalimumab-adbm Pen 40 MG/0.4 ML - Starter Pack for Crohn's Disease, Ulcerative Colitis or Hidradenitis Suppurativa (6 count) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680759 | adalimumab-adbm Pen 40 MG/0.4 ML - Starter Pack for Crohn's Disease, Ulcerative Colitis or Hidradenitis Suppurativa (6 count) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680760 | CYLTEZO Pen 40 MG/0.4 ML - Starter Pack for Crohn's Disease, Ulcerative Colitis or Hidradenitis Suppurativa (6 count) | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2680760 | CYLTEZO Pen 40 MG/0.4 ML - Starter Pack for Crohn's Disease, Ulcerative Colitis or Hidradenitis Suppurativa (6 count) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680760 | CYLTEZO Pen 40 MG/0.4 ML - Starter Pack for Crohn's Disease, Ulcerative Colitis or Hidradenitis Suppurativa (6 count) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680779 | valbenazine 40 MG Sprinkle Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2680779 | valbenazine 40 MG Sprinkle Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680779 | valbenazine 40 MG Sprinkle Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680780 | INGREZZA SPRINKLE 40 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680780 | INGREZZA SPRINKLE 40 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680780 | INGREZZA SPRINKLE 40 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2680781 | valbenazine 60 MG Sprinkle Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2680781 | valbenazine 60 MG Sprinkle Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680781 | valbenazine 60 MG Sprinkle Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680782 | INGREZZA SPRINKLE 60 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680782 | INGREZZA SPRINKLE 60 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680782 | INGREZZA SPRINKLE 60 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2680783 | valbenazine 80 MG Sprinkle Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2680783 | valbenazine 80 MG Sprinkle Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680783 | valbenazine 80 MG Sprinkle Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680784 | INGREZZA SPRINKLE 80 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2680784 | INGREZZA SPRINKLE 80 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2680784 | INGREZZA SPRINKLE 80 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2681010 | 1 nighttime (acetaminophen 1000 MG / diphenhydrAMINE HCl 50 MG in 30 mL Oral Solution) / 1 daytime (acetaminophen 1000 MG in 30 mL Oral Solution) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2681010 | 1 nighttime (acetaminophen 1000 MG / diphenhydrAMINE HCl 50 MG in 30 mL Oral Solution) / 1 daytime (acetaminophen 1000 MG in 30 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2681010 | 1 nighttime (acetaminophen 1000 MG / diphenhydrAMINE HCl 50 MG in 30 mL Oral Solution) / 1 daytime (acetaminophen 1000 MG in 30 mL Oral Solution) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2681010 | 1 nighttime (acetaminophen 1000 MG / diphenhydrAMINE HCl 50 MG in 30 mL Oral Solution) / 1 daytime (acetaminophen 1000 MG in 30 mL Oral Solution) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2681010 | 1 nighttime (acetaminophen 1000 MG / diphenhydrAMINE HCl 50 MG in 30 mL Oral Solution) / 1 daytime (acetaminophen 1000 MG in 30 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2681011 | fidanacogene elaparvovec | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2681012 | upadacitinib 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2681013 | upadacitinib Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2681014 | upadacitinib Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2681015 | upadacitinib 1 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2681015 | upadacitinib 1 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2681015 | upadacitinib 1 MG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2681016 | upadacitinib 1 MG/ML [Rinvoq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2681017 | Rinvoq Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2681018 | upadacitinib Oral Solution [Rinvoq] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2681019 | RINVOQ LQ 1 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2681019 | RINVOQ LQ 1 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2681019 | RINVOQ LQ 1 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2681019 | RINVOQ LQ 1 MG in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2681020 | fidanacogene elaparvovec-dzkt | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2681021 | fidanacogene elaparvovec-dzkt 10000000000000 VECTOR-GENOMES/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2681022 | fidanacogene elaparvovec Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2681023 | fidanacogene elaparvovec Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2681026 | fidanacogene elaparvovec-dzkt 1.0 x 10(13) vg/ML in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2681026 | fidanacogene elaparvovec-dzkt 1.0 x 10(13) vg/ML in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2681026 | fidanacogene elaparvovec-dzkt 1.0 x 10(13) vg/ML in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2681026 | fidanacogene elaparvovec-dzkt 1.0 x 10(13) vg/ML in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2681027 | fidanacogene elaparvovec-dzkt 10000000000000 VECTOR-GENOMES/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2681028 | Beqvez | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2681029 | fidanacogene elaparvovec-dzkt 10000000000000 VECTOR-GENOMES/ML [Beqvez] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2681030 | Beqvez Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2681031 | fidanacogene elaparvovec Injection [Beqvez] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2681033 | BEQVEZ 1.0 x 10(13) vg/ML in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2681033 | BEQVEZ 1.0 x 10(13) vg/ML in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2681033 | BEQVEZ 1.0 x 10(13) vg/ML in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2681033 | BEQVEZ 1.0 x 10(13) vg/ML in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2681033 | BEQVEZ 1.0 x 10(13) vg/ML in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2681034 | fidanacogene elaparvovec-dzkt 10000000000000 VECTOR-GENOMES/ML Injection [Beqvez] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2681034 | fidanacogene elaparvovec-dzkt 10000000000000 VECTOR-GENOMES/ML Injection [Beqvez] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2681035 | fidanacogene elaparvovec-dzkt Kit Patient Weight < 75 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2681035 | fidanacogene elaparvovec-dzkt Kit Patient Weight < 75 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2681035 | fidanacogene elaparvovec-dzkt Kit Patient Weight < 75 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2681036 | BEQVEZ Kit Patient Weight < 75 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2681036 | BEQVEZ Kit Patient Weight < 75 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2681036 | BEQVEZ Kit Patient Weight < 75 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2681037 | fidanacogene elaparvovec-dzkt Kit Patient Weight 75 - 95 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2681037 | fidanacogene elaparvovec-dzkt Kit Patient Weight 75 - 95 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2681037 | fidanacogene elaparvovec-dzkt Kit Patient Weight 75 - 95 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2681038 | BEQVEZ Kit Patient Weight 75 - 95 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2681038 | BEQVEZ Kit Patient Weight 75 - 95 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2681038 | BEQVEZ Kit Patient Weight 75 - 95 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2681039 | fidanacogene elaparvovec-dzkt Kit Patient Weight 95 - 115 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2681039 | fidanacogene elaparvovec-dzkt Kit Patient Weight 95 - 115 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2681039 | fidanacogene elaparvovec-dzkt Kit Patient Weight 95 - 115 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2681040 | BEQVEZ Kit Patient Weight 95 - 115 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2681040 | BEQVEZ Kit Patient Weight 95 - 115 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2681040 | BEQVEZ Kit Patient Weight 95 - 115 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2681041 | fidanacogene elaparvovec-dzkt Kit Patient Weight 115 - 135 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2681041 | fidanacogene elaparvovec-dzkt Kit Patient Weight 115 - 135 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2681041 | fidanacogene elaparvovec-dzkt Kit Patient Weight 115 - 135 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2681042 | BEQVEZ Kit Patient Weight 115 - 135 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2681042 | BEQVEZ Kit Patient Weight 115 - 135 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2681042 | BEQVEZ Kit Patient Weight 115 - 135 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2681043 | edaravone 0.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2681044 | edaravone 60 MG in 100 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2681044 | edaravone 60 MG in 100 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2681044 | edaravone 60 MG in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2681045 | edaravone 0.6 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 26824 | Acyl-CoA reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26824 | Acyl-CoA reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26824 | Acyl-CoA reductase | Designated preferred name (PT) | NO | |
| RxCUI: 26824 | Acyl-CoA reductase | Full form of descriptor (FN) | NO | |
| RxCUI: 26824 | Acyl-CoA reductase | Designated preferred name (PT) | NO | |
| RxCUI: 26824 | Acyl-CoA reductase | Full form of descriptor (FN) | NO | |
| RxCUI: 2682429 | apremilast starter pack 10 MG (4), 20 MG (51) Oral Tablet 28-Day Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2682429 | apremilast starter pack 10 MG (4), 20 MG (51) Oral Tablet 28-Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682429 | apremilast starter pack 10 MG (4), 20 MG (51) Oral Tablet 28-Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682430 | Otezla 28-Day 10/20 Starter Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2682430 | Otezla 28-Day 10/20 Starter Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682430 | Otezla 28-Day 10/20 Starter Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682431 | apremilast starter pack 10 MG (4), 20 MG (23) Oral Tablet 14-Day Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2682431 | apremilast starter pack 10 MG (4), 20 MG (23) Oral Tablet 14-Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682431 | apremilast starter pack 10 MG (4), 20 MG (23) Oral Tablet 14-Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682432 | Otezla 14-Day 10/20 Starter Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2682432 | Otezla 14-Day 10/20 Starter Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682432 | Otezla 14-Day 10/20 Starter Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682434 | tovorafenib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2682436 | tovorafenib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2682437 | tovorafenib Oral Powder Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2682438 | tovorafenib Powder for Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2682439 | tovorafenib 25 MG in 1 mL Powder for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682439 | tovorafenib 25 MG in 1 mL Powder for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682439 | tovorafenib 25 MG in 1 mL Powder for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682439 | tovorafenib 25 MG in 1 mL Powder for Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2682440 | Ojemda | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2682442 | Ojemda Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2682443 | Ojemda Oral Powder Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2682444 | tovorafenib Powder for Oral Suspension [Ojemda] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2682445 | ojemda 25 MG in 1 mL Powder for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682445 | ojemda 25 MG in 1 mL Powder for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682445 | ojemda 25 MG in 1 mL Powder for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682445 | ojemda 25 MG in 1 mL Powder for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682445 | ojemda 25 MG in 1 mL Powder for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2682447 | tovorafenib 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2682448 | tovorafenib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2682449 | tovorafenib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2682450 | tovorafenib 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682450 | tovorafenib 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2682450 | tovorafenib 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682451 | tovorafenib 100 MG [Ojemda] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2682452 | Ojemda Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2682453 | tovorafenib Oral Tablet [Ojemda] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2682454 | ojemda 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682454 | ojemda 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682454 | ojemda 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2682551 | tangeretin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2682552 | torsemide 2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2682553 | torsemide Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2682554 | torsemide Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2682555 | torsemide 2 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2682555 | torsemide 2 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2682556 | Upcard | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2682557 | torsemide 2 MG/ML [Upcard] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2682558 | Upcard Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2682559 | Upcard Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2682560 | torsemide Oral Solution [Upcard] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2682561 | UpCard-CA1 2 MG/mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2682561 | UpCard-CA1 2 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2682561 | UpCard-CA1 2 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2682561 | UpCard-CA1 2 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2682562 | diazepam Buccal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2682562 | diazepam Buccal Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2682563 | diazepam Buccal Film | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2682563 | diazepam Buccal Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2682564 | diazePAM 5 MG Buccal Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682564 | diazePAM 5 MG Buccal Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2682564 | diazePAM 5 MG Buccal Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2682565 | Libervant | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2682566 | diazepam 5 MG [Libervant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2682566 | diazepam 5 MG [Libervant] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2682567 | Libervant Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2682568 | Libervant Buccal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2682569 | diazepam Buccal Film [Libervant] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2682569 | diazepam Buccal Film [Libervant] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2682570 | Libervant 5 MG Buccal Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2682570 | Libervant 5 MG Buccal Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2682570 | Libervant 5 MG Buccal Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682570 | Libervant 5 MG Buccal Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682571 | diazePAM 10 MG Buccal Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682571 | diazePAM 10 MG Buccal Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2682571 | diazePAM 10 MG Buccal Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2682572 | diazepam 10 MG [Libervant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2682572 | diazepam 10 MG [Libervant] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2682573 | Libervant 10 MG Buccal Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2682573 | Libervant 10 MG Buccal Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2682573 | Libervant 10 MG Buccal Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682573 | Libervant 10 MG Buccal Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682574 | diazepam 12.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2682574 | diazepam 12.5 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2682575 | diazePAM 12.5 MG Buccal Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682575 | diazePAM 12.5 MG Buccal Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2682575 | diazePAM 12.5 MG Buccal Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2682576 | diazepam 12.5 MG [Libervant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2682576 | diazepam 12.5 MG [Libervant] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2682577 | Libervant 12.5 MG Buccal Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2682577 | Libervant 12.5 MG Buccal Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2682577 | Libervant 12.5 MG Buccal Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682577 | Libervant 12.5 MG Buccal Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682578 | diazePAM 15 MG Buccal Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682578 | diazePAM 15 MG Buccal Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2682578 | diazePAM 15 MG Buccal Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2682579 | diazepam 15 MG [Libervant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2682579 | diazepam 15 MG [Libervant] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2682580 | Libervant 15 MG Buccal Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2682580 | Libervant 15 MG Buccal Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2682580 | Libervant 15 MG Buccal Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682580 | Libervant 15 MG Buccal Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682581 | diazePAM 7.5 MG Buccal Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682581 | diazePAM 7.5 MG Buccal Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2682581 | diazePAM 7.5 MG Buccal Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2682582 | diazepam 7.5 MG [Libervant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2682582 | diazepam 7.5 MG [Libervant] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2682583 | Libervant 7.5 MG Buccal Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2682583 | Libervant 7.5 MG Buccal Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2682583 | Libervant 7.5 MG Buccal Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682583 | Libervant 7.5 MG Buccal Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682584 | chlorhexidine 1 % / salicylic acid 1 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2682584 | chlorhexidine 1 % / salicylic acid 1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2682584 | chlorhexidine 1 % / salicylic acid 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26826 | hexafluronium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 26826 | hexafluronium | Designated preferred name (PT) | NO | |
| RxCUI: 26826 | hexafluronium | Full form of descriptor (FN) | NO | |
| RxCUI: 26826 | hexafluronium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2682677 | nogapendekin alfa inbakicept-pmln | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2682678 | nogapendekin alfa inbakicept | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2682679 | nogapendekin alfa inbakicept-pmln 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2682680 | nogapendekin alfa inbakicept Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2682681 | nogapendekin alfa inbakicept Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2682684 | nogapendekin alfa inbakicept-pmln 400 MCG in 0.4 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2682684 | nogapendekin alfa inbakicept-pmln 400 MCG in 0.4 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682684 | nogapendekin alfa inbakicept-pmln 400 MCG in 0.4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682685 | nogapendekin alfa inbakicept-pmln 1 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2682686 | Anktiva | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2682687 | nogapendekin alfa inbakicept-pmln 1 MG/ML [Anktiva] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2682688 | Anktiva Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2682689 | nogapendekin alfa inbakicept Injection [Anktiva] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2682691 | Anktiva 400 MCG in 0.4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682691 | Anktiva 400 MCG in 0.4 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2682691 | Anktiva 400 MCG in 0.4 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682691 | Anktiva 400 MCG in 0.4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682692 | nogapendekin alfa inbakicept-pmln 1 MG/ML Injection [Anktiva] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2682692 | nogapendekin alfa inbakicept-pmln 1 MG/ML Injection [Anktiva] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2682693 | phenoxybenzamine hydrochloride 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2682734 | Clematis viorna whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2682738 | hydroxyurea 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2682739 | hydroxyurea Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2682740 | hydroxyurea Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2682741 | hydroxyurea 100 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682741 | hydroxyurea 100 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682741 | hydroxyurea 100 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682741 | hydroxyurea 100 MG in 1 mL Oral Solution | Designated preferred name (PT) | YES | |
| RxCUI: 2682741 | hydroxyurea 100 MG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2682741 | hydroxyurea 100 MG in 1 mL Oral Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 2682744 | cyanocobalamin 1500 MCG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682744 | cyanocobalamin 1500 MCG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682744 | cyanocobalamin 1500 MCG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2682745 | levomefolate calcium 1.7 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2682746 | cholecalciferol 125 MCG (5000 UNT) / levomefolate calcium 1700 MCG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2682746 | cholecalciferol 125 MCG (5000 UNT) / levomefolate calcium 1700 MCG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682746 | cholecalciferol 125 MCG (5000 UNT) / levomefolate calcium 1700 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682747 | vitamin K2 0.18 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2682748 | cholecalciferol 125 MCG (5000 UNT) / vitamin K2 180 MCG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2682748 | cholecalciferol 125 MCG (5000 UNT) / vitamin K2 180 MCG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682748 | cholecalciferol 125 MCG (5000 UNT) / vitamin K2 180 MCG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682748 | cholecalciferol 125 MCG (5000 UNT) / vitamin K2 180 MCG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682751 | potassium nitrate 0.045 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2682752 | sodium fluoride 1.1 % / potassium nitrate 4.5 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682752 | sodium fluoride 1.1 % / potassium nitrate 4.5 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682752 | sodium fluoride 1.1 % / potassium nitrate 4.5 % Toothpaste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2682752 | sodium fluoride 1.1 % / potassium nitrate 4.5 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682752 | sodium fluoride 1.1 % / potassium nitrate 4.5 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682809 | Ricinus communis leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2682816 | sodium fluoride 0.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2682817 | sodium fluoride 0.03 % (fluoride ion 0.02 % ) Mouthwash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2682817 | sodium fluoride 0.03 % (fluoride ion 0.02 % ) Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2682817 | sodium fluoride 0.03 % (fluoride ion 0.02 % ) Mouthwash | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2682819 | chloroxylenol 1.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2682820 | chloroxylenol 0.15 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2682820 | chloroxylenol 0.15 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2682820 | chloroxylenol 0.15 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2682874 | tovorafenib 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2682876 | tovorafenib 300 MG [Ojemda] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2682953 | dioctyldodecyl adipate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2682954 | tarlatamab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2682955 | tarlatamab-dlle | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2682956 | tarlatamab-dlle 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2682957 | tarlatamab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2682958 | tarlatamab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2682961 | tarlatamab-dlle 1 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682961 | tarlatamab-dlle 1 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2682962 | Imdelltra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2682963 | tarlatamab-dlle 1 MG [Imdelltra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2682964 | Imdelltra Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2682965 | tarlatamab Injection [Imdelltra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2682967 | IMDELLTRA 1 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682967 | IMDELLTRA 1 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682967 | IMDELLTRA 1 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2682968 | tarlatamab-dlle 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2682969 | tarlatamab-dlle 10 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682969 | tarlatamab-dlle 10 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2682970 | tarlatamab-dlle 10 MG [Imdelltra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2682971 | IMDELLTRA 10 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2682971 | IMDELLTRA 10 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2682971 | IMDELLTRA 10 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2683 | Colchicine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2683 | Colchicine | Designated preferred name (PT) | YES | |
| RxCUI: 2683 | Colchicine | Full form of descriptor (FN) | YES | |
| RxCUI: 2683 | Colchicine | Designated preferred name (PT) | YES | |
| RxCUI: 2683 | Colchicine | Full form of descriptor (FN) | YES | |
| RxCUI: 2683092 | petrolatum 0.472 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2683093 | petrolatum 47.2 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2683093 | petrolatum 47.2 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2683093 | petrolatum 47.2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2683094 | acetoin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2683194 | Chenopodium quinoa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2683195 | Rheum pumilum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2683196 | Aconitum pendulum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2683200 | hydroxypropyl guar hydroxypropyltrimonium chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2683201 | camphor 3.6 % / menthol 16 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2683201 | camphor 3.6 % / menthol 16 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2683201 | camphor 3.6 % / menthol 16 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2683202 | camphor 3.6 % / menthol 16 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2683202 | camphor 3.6 % / menthol 16 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2683202 | camphor 3.6 % / menthol 16 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2683226 | 1 daytime (dextromethorphan HBr 5 MG / guaiFENesin 100 MG in 5 mL Oral Solution) / 1 nighttime (diphenhydrAMINE hydrochloride 12.5 MG in 5 mL Oral Solution) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2683226 | 1 daytime (dextromethorphan HBr 5 MG / guaiFENesin 100 MG in 5 mL Oral Solution) / 1 nighttime (diphenhydrAMINE hydrochloride 12.5 MG in 5 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2683226 | 1 daytime (dextromethorphan HBr 5 MG / guaiFENesin 100 MG in 5 mL Oral Solution) / 1 nighttime (diphenhydrAMINE hydrochloride 12.5 MG in 5 mL Oral Solution) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2683226 | 1 daytime (dextromethorphan HBr 5 MG / guaiFENesin 100 MG in 5 mL Oral Solution) / 1 nighttime (diphenhydrAMINE hydrochloride 12.5 MG in 5 mL Oral Solution) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2683226 | 1 daytime (dextromethorphan HBr 5 MG / guaiFENesin 100 MG in 5 mL Oral Solution) / 1 nighttime (diphenhydrAMINE hydrochloride 12.5 MG in 5 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2683281 | deutetrabenazine 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2683282 | deutetrabenazine 30 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2683282 | deutetrabenazine 30 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2683282 | deutetrabenazine 30 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2683283 | deutetrabenazine 30 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2683283 | deutetrabenazine 30 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2683284 | deutetrabenazine 30 MG [Austedo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2683285 | Austedo XR 30 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2683285 | Austedo XR 30 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2683285 | Austedo XR 30 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2683286 | Austedo 30 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2683286 | Austedo 30 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2683286 | Austedo 30 MG Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2683287 | deutetrabenazine 36 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2683288 | deutetrabenazine 36 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2683288 | deutetrabenazine 36 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2683288 | deutetrabenazine 36 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2683289 | deutetrabenazine 36 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2683289 | deutetrabenazine 36 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2683290 | deutetrabenazine 36 MG [Austedo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2683291 | Austedo XR 36 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2683291 | Austedo XR 36 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2683291 | Austedo XR 36 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2683292 | Austedo 36 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2683292 | Austedo 36 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2683292 | Austedo 36 MG Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2683293 | deutetrabenazine 42 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2683294 | deutetrabenazine XR 42 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2683294 | deutetrabenazine XR 42 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2683294 | deutetrabenazine XR 42 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2683295 | deutetrabenazine 42 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2683295 | deutetrabenazine 42 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2683295 | deutetrabenazine 42 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2683296 | deutetrabenazine 42 MG [Austedo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2683297 | Austedo XR 42 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2683297 | Austedo XR 42 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2683297 | Austedo XR 42 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2683298 | Austedo 42 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2683298 | Austedo 42 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2683298 | Austedo 42 MG Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2683299 | deutetrabenazine 48 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2683300 | deutetrabenazine 48 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2683300 | deutetrabenazine 48 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2683300 | deutetrabenazine 48 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2683301 | deutetrabenazine 48 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2683301 | deutetrabenazine 48 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2683301 | deutetrabenazine 48 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2683302 | deutetrabenazine 48 MG [Austedo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2683303 | Austedo XR 48 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2683303 | Austedo XR 48 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2683303 | Austedo XR 48 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2683304 | Austedo 48 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2683304 | Austedo 48 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2683304 | Austedo 48 MG Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2683305 | furosemide 500 MG in 50 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2683305 | furosemide 500 MG in 50 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2683305 | furosemide 500 MG in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2683306 | furosemide 1000 MG in 100 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2683306 | furosemide 1000 MG in 100 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2683306 | furosemide 1000 MG in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2683415 | demeton-S-methylsulfone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2683416 | disodium.alpha.-tocopheryl phosphate, D- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2683419 | acetaminophen 250 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2683419 | acetaminophen 250 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2683419 | acetaminophen 250 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2683419 | acetaminophen 250 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2683420 | acetaminophen 320 MG / diphenhydrAMINE HCl 12.5 MG in 10 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2683420 | acetaminophen 320 MG / diphenhydrAMINE HCl 12.5 MG in 10 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2683420 | acetaminophen 320 MG / diphenhydrAMINE HCl 12.5 MG in 10 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2683420 | acetaminophen 320 MG / diphenhydrAMINE HCl 12.5 MG in 10 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2683420 | acetaminophen 320 MG / diphenhydrAMINE HCl 12.5 MG in 10 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2683420 | acetaminophen 320 MG / diphenhydrAMINE HCl 12.5 MG in 10 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2683420 | acetaminophen 320 MG / diphenhydrAMINE HCl 12.5 MG in 10 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2683421 | brompheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG in 10 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2683421 | brompheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG in 10 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2683421 | brompheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG in 10 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2683422 | 1 daytime (brompheniramine maleate 2 MG / dextromethorphan HBr 10 MG in 10 mL Oral Solution) / 1 nighttime (diphenhydrAMINE HCl 12.5 MG in 10 mL Oral Solution) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2683422 | 1 daytime (brompheniramine maleate 2 MG / dextromethorphan HBr 10 MG in 10 mL Oral Solution) / 1 nighttime (diphenhydrAMINE HCl 12.5 MG in 10 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2683422 | 1 daytime (brompheniramine maleate 2 MG / dextromethorphan HBr 10 MG in 10 mL Oral Solution) / 1 nighttime (diphenhydrAMINE HCl 12.5 MG in 10 mL Oral Solution) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2683422 | 1 daytime (brompheniramine maleate 2 MG / dextromethorphan HBr 10 MG in 10 mL Oral Solution) / 1 nighttime (diphenhydrAMINE HCl 12.5 MG in 10 mL Oral Solution) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2683422 | 1 daytime (brompheniramine maleate 2 MG / dextromethorphan HBr 10 MG in 10 mL Oral Solution) / 1 nighttime (diphenhydrAMINE HCl 12.5 MG in 10 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2683423 | dextromethorphan hydrobromide 10 MG / doxylamine succinate 6.25 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2683423 | dextromethorphan hydrobromide 10 MG / doxylamine succinate 6.25 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2683423 | dextromethorphan hydrobromide 10 MG / doxylamine succinate 6.25 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2683424 | dextromethorphan hydrobromide 10 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2683424 | dextromethorphan hydrobromide 10 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2683424 | dextromethorphan hydrobromide 10 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2683425 | 1 daytime (dextromethorphan HBr 10 MG Chewable Tablet) / 1 nighttime (dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG Chewable Tablet) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2683425 | 1 daytime (dextromethorphan HBr 10 MG Chewable Tablet) / 1 nighttime (dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG Chewable Tablet) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2683425 | 1 daytime (dextromethorphan HBr 10 MG Chewable Tablet) / 1 nighttime (dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG Chewable Tablet) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2683673 | cenobamate Titration Pack - 12.5 MG 14 Count | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2683673 | cenobamate Titration Pack - 12.5 MG 14 Count | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2683673 | cenobamate Titration Pack - 12.5 MG 14 Count | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2683674 | XCOPRI Titration Pack - 12.5 MG 14 Count | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 2683674 | XCOPRI Titration Pack - 12.5 MG 14 Count | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2683674 | XCOPRI Titration Pack - 12.5 MG 14 Count | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2683735 | hydrocortisone acetate 1 % / lidocaine hydrochloride 3.88 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2683735 | hydrocortisone acetate 1 % / lidocaine hydrochloride 3.88 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2683735 | hydrocortisone acetate 1 % / lidocaine hydrochloride 3.88 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2683736 | clobetasol Ophthalmic Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2683737 | clobetasol Ophthalmic Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2683740 | clobetasol propionate 0.05 % Ophthalmic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2683740 | clobetasol propionate 0.05 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2683740 | clobetasol propionate 0.05 % Ophthalmic Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 26839 | Hexamethonium | Designated preferred name (PT) | NO | |
| RxCUI: 26839 | Hexamethonium | Full form of descriptor (FN) | NO | |
| RxCUI: 2684021 | mavorixafor | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2684022 | mavorixafor 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2684023 | mavorixafor Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2684024 | mavorixafor Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2684025 | mavorixafor Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2684026 | mavorixafor 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2684026 | mavorixafor 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2684027 | Xolremdi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2684028 | mavorixafor 100 MG [Xolremdi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2684029 | Xolremdi Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2684030 | Xolremdi Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2684031 | mavorixafor Oral Capsule [Xolremdi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2684032 | XOLREMDI 100 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2684032 | XOLREMDI 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2684032 | XOLREMDI 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2684033 | lidocaine hydrochloride 50 MG/ML [Lidotral] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2684034 | lidocaine Topical Spray [Lidotral] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2684036 | Lidotral 5 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2684036 | Lidotral 5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2684036 | Lidotral 5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2684036 | Lidotral 5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2684038 | ethanol 0.566 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2684039 | ethanol 56.6 % / lidocaine HCl 2 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2684039 | ethanol 56.6 % / lidocaine HCl 2 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2684039 | ethanol 56.6 % / lidocaine HCl 2 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2684039 | ethanol 56.6 % / lidocaine HCl 2 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2684040 | menthol 28.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2684041 | methyl salicylate 182 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2684042 | menthol 2.84 % / methyl salicylate 18.24 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2684042 | menthol 2.84 % / methyl salicylate 18.24 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2684042 | menthol 2.84 % / methyl salicylate 18.24 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2684625 | cholecalciferol 100 MCG (4000 UNT) / menatetrenone 100 MCG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2684625 | cholecalciferol 100 MCG (4000 UNT) / menatetrenone 100 MCG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2684625 | cholecalciferol 100 MCG (4000 UNT) / menatetrenone 100 MCG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2684626 | menthol 1.7 MG [Ricola] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2684627 | Ricola 1.7 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2684627 | Ricola 1.7 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2684627 | Ricola 1.7 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2684846 | Myhibbin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2684847 | mycophenolate mofetil 200 MG/ML [Myhibbin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2684848 | Myhibbin Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2684849 | Myhibbin Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2684850 | mycophenolate mofetil Oral Suspension [Myhibbin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2684851 | Myhibbin 200 MG in 1 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2684851 | Myhibbin 200 MG in 1 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2684851 | Myhibbin 200 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2684851 | Myhibbin 200 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 26849 | hexamidine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 26849 | hexamidine | Designated preferred name (PT) | NO | |
| RxCUI: 26849 | hexamidine | Full form of descriptor (FN) | NO | |
| RxCUI: 2684921 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2684921 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2684921 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2684921 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2684921 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2684921 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2684921 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2684922 | menthol 26.7 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2684923 | menthol 2.667 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2684923 | menthol 2.667 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2684923 | menthol 2.667 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2684924 | colloidal oatmeal 0.5 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2684924 | colloidal oatmeal 0.5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2684924 | colloidal oatmeal 0.5 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2684941 | elafibranor | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2684942 | elafibranor 80 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2684943 | elafibranor Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2684944 | elafibranor Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2684945 | elafibranor Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2684946 | elafibranor 80 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2684946 | elafibranor 80 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2684946 | elafibranor 80 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2684947 | Iqirvo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2684948 | elafibranor 80 MG [Iqirvo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2684949 | Iqirvo Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2684950 | Iqirvo Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2684951 | elafibranor Oral Tablet [Iqirvo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2684952 | IQIRVO 80 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2684952 | IQIRVO 80 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2684952 | IQIRVO 80 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2684977 | diheptyl adipate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2684979 | Ilex cornuta whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2684980 | Impatiens walleriana whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2684981 | pentapeptide-18 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2684982 | vitexin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2684985 | lidocaine hydrochloride 5 % / phenylephrine HCl 0.25 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2684985 | lidocaine hydrochloride 5 % / phenylephrine HCl 0.25 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2684985 | lidocaine hydrochloride 5 % / phenylephrine HCl 0.25 % Rectal Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2684986 | Lentocilin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2684987 | penicillin G benzathine 1200000 UNT [Lentocilin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2684988 | Lentocilin Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2684989 | penicillin G Injection [Lentocilin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2684991 | Lentocilin 1,200,000 UNT Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2684991 | Lentocilin 1,200,000 UNT Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2684991 | Lentocilin 1,200,000 UNT Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2684993 | dioctyl adipate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2685 | Colestipol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2685 | Colestipol | Designated preferred name (PT) | YES | |
| RxCUI: 2685 | Colestipol | Full form of descriptor (FN) | YES | |
| RxCUI: 2685 | Colestipol | Designated preferred name (PT) | YES | |
| RxCUI: 2685 | Colestipol | Full form of descriptor (FN) | YES | |
| RxCUI: 2685002 | respiratory syncytial virus pre-fusion F glycoprotein mRNA | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2685003 | respiratory syncytial virus pre-fusion F glycoprotein mRNA 0.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2685004 | respiratory syncytial virus pre-fusion F glycoprotein mRNA Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2685005 | respiratory syncytial virus pre-fusion F glycoprotein mRNA Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2685006 | respiratory syncytial virus pre-fusion F glycoprotein mRNA 50 MCG in 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2685006 | respiratory syncytial virus pre-fusion F glycoprotein mRNA 50 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685006 | respiratory syncytial virus pre-fusion F glycoprotein mRNA 50 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685007 | respiratory syncytial virus pre-fusion F glycoprotein mRNA 0.1 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2685008 | Mresvia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2685009 | respiratory syncytial virus pre-fusion F glycoprotein mRNA 0.1 MG/ML [Mresvia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2685010 | Mresvia Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2685011 | respiratory syncytial virus pre-fusion F glycoprotein mRNA Prefilled Syringe [Mresvia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2685012 | mRESVIA 50 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685012 | mRESVIA 50 MCG in 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2685012 | mRESVIA 50 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685012 | mRESVIA 50 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685013 | respiratory syncytial virus pre-fusion F glycoprotein mRNA 0.1 MG/ML Prefilled Syringe [Mresvia] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2685013 | respiratory syncytial virus pre-fusion F glycoprotein mRNA 0.1 MG/ML Prefilled Syringe [Mresvia] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2685014 | deferiprone 1000 MG Twice-Daily Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685014 | deferiprone 1000 MG Twice-Daily Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685014 | deferiprone 1000 MG Twice-Daily Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2685015 | Ferriprox 1000 MG Twice-Daily Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685015 | Ferriprox 1000 MG Twice-Daily Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685015 | Ferriprox 1000 MG Twice-Daily Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2685015 | Ferriprox 1000 MG Twice-Daily Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685197 | Torpenz | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2685198 | everolimus 2.5 MG [Torpenz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2685199 | Torpenz Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2685200 | Torpenz Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2685201 | everolimus Oral Tablet [Torpenz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2685202 | TORPENZ 2.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2685202 | TORPENZ 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685202 | TORPENZ 2.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685203 | everolimus 10 MG [Torpenz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2685204 | TORPENZ 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2685204 | TORPENZ 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685204 | TORPENZ 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685205 | everolimus 5 MG [Torpenz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2685206 | TORPENZ 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2685206 | TORPENZ 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685206 | TORPENZ 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685207 | everolimus 7.5 MG [Torpenz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2685208 | TORPENZ 7.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2685208 | TORPENZ 7.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685208 | TORPENZ 7.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685209 | acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2685209 | acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2685209 | acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2685210 | dextromethorphan hydrobromide 15 MG / doxylamine succinate 6.25 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685210 | dextromethorphan hydrobromide 15 MG / doxylamine succinate 6.25 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2685211 | mineral oil 0.744 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2685212 | mineral oil / tetracaine Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2685213 | mineral oil 74.4 % / tetracaine 2 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2685213 | mineral oil 74.4 % / tetracaine 2 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2685213 | mineral oil 74.4 % / tetracaine 2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2685214 | vigabatrin 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2685215 | vigabatrin Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2685216 | vigabatrin Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2685217 | vigabatrin 100 MG in 1 mL Concentrate for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685217 | vigabatrin 100 MG in 1 mL Concentrate for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685217 | vigabatrin 100 MG in 1 mL Concentrate for Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2685218 | Vigafyde | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2685219 | vigabatrin 100 MG/ML [Vigafyde] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2685220 | Vigafyde Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2685221 | Vigafyde Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2685222 | vigabatrin Oral Solution [Vigafyde] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2685223 | VIGAFYDE 100 MG in 1 mL Concentrate for Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2685223 | VIGAFYDE 100 MG in 1 mL Concentrate for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685223 | VIGAFYDE 100 MG in 1 mL Concentrate for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685223 | VIGAFYDE 100 MG in 1 mL Concentrate for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685224 | Trimazole | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2685225 | clotrimazole 10 MG/ML [Trimazole] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2685226 | Trimazole Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2685227 | clotrimazole Topical Cream [Trimazole] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2685228 | Trimazole 1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2685228 | Trimazole 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685228 | Trimazole 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685228 | Trimazole 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685236 | imetelstat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2685237 | imetelstat sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2685238 | imetelstat 47 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2685239 | imetelstat Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2685240 | imetelstat Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2685241 | imetelstat 47 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685241 | imetelstat 47 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685241 | imetelstat 47 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2685242 | Rytelo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2685243 | imetelstat 47 MG [Rytelo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2685244 | Rytelo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2685245 | imetelstat Injection [Rytelo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2685246 | RYTELO 47 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2685246 | RYTELO 47 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685246 | RYTELO 47 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685247 | imetelstat 188 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2685248 | imetelstat 188 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685248 | imetelstat 188 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685248 | imetelstat 188 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2685249 | imetelstat 188 MG [Rytelo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2685250 | RYTELO 188 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2685250 | RYTELO 188 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685250 | RYTELO 188 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685256 | Tricylate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2685257 | menthol 20 MG/ML / methyl salicylate 100 MG/ML [Tricylate] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2685258 | Tricylate Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2685259 | menthol / methyl salicylate Topical Cream [Tricylate] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2685260 | Tricylate 2 % / 10 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2685260 | Tricylate 2 % / 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685260 | Tricylate 2 % / 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685261 | tolnaftate Topical Cream [Tritolnacide] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2685262 | TriTolnacide C 1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2685262 | TriTolnacide C 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685262 | TriTolnacide C 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685262 | TriTolnacide C 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685263 | brompheniramine maleate 2 MG in 10 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2685263 | brompheniramine maleate 2 MG in 10 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685263 | brompheniramine maleate 2 MG in 10 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685292 | corticotropin Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2685293 | corticotropin 80 UNT in 1 ML Prefilled Self-Controlled Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2685293 | corticotropin 80 UNT in 1 ML Prefilled Self-Controlled Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685293 | corticotropin 80 UNT in 1 ML Prefilled Self-Controlled Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685294 | corticotropin 80 UNT/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2685294 | corticotropin 80 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2685295 | corticotropin Prefilled Syringe [Acthar] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2685296 | Acthar Gel 80 UNT in 1 ML Prefilled SelfJect Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685296 | Acthar Gel 80 UNT in 1 ML Prefilled SelfJect Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2685296 | Acthar Gel 80 UNT in 1 ML Prefilled SelfJect Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685296 | Acthar Gel 80 UNT in 1 ML Prefilled SelfJect Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685297 | corticotropin 80 UNT/ML Prefilled Syringe [Acthar] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2685297 | corticotropin 80 UNT/ML Prefilled Syringe [Acthar] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2685298 | corticotropin 40 UNT in 0.5 ML Prefilled Self-Controlled Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2685298 | corticotropin 40 UNT in 0.5 ML Prefilled Self-Controlled Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685298 | corticotropin 40 UNT in 0.5 ML Prefilled Self-Controlled Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685299 | Acthar Gel 40 UNT in 0.5 ML Prefilled SelfJect Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685299 | Acthar Gel 40 UNT in 0.5 ML Prefilled SelfJect Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2685299 | Acthar Gel 40 UNT in 0.5 ML Prefilled SelfJect Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685299 | Acthar Gel 40 UNT in 0.5 ML Prefilled SelfJect Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685302 | dictamnine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2685346 | carprofen 50 MG/ML [Carprovet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2685347 | Carprovet Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2685348 | carprofen Injectable Solution [Carprovet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2685349 | Carprovet 50 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2685349 | Carprovet 50 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2685349 | Carprovet 50 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2685485 | benzocaine Vaginal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2685486 | benzocaine Vaginal Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2685487 | benzocaine 5 % Vaginal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2685487 | benzocaine 5 % Vaginal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2685487 | benzocaine 5 % Vaginal Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2685488 | diphenhydrAMINE hydrochloride 12.5 MG in 15 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2685488 | diphenhydrAMINE hydrochloride 12.5 MG in 15 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2685488 | diphenhydrAMINE hydrochloride 12.5 MG in 15 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2685488 | diphenhydrAMINE hydrochloride 12.5 MG in 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2685488 | diphenhydrAMINE hydrochloride 12.5 MG in 15 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2685489 | ondansetron 16 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685489 | ondansetron 16 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2685490 | 1 daytime (dextromethorphan HBr 10 MG / guaiFENesin 200 MG in 15 mL Oral Solution) / 1 nighttime (diphenhydrAMINE hydrochloride 12.5 MG in 15 mL Oral Solution) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2685490 | 1 daytime (dextromethorphan HBr 10 MG / guaiFENesin 200 MG in 15 mL Oral Solution) / 1 nighttime (diphenhydrAMINE hydrochloride 12.5 MG in 15 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2685490 | 1 daytime (dextromethorphan HBr 10 MG / guaiFENesin 200 MG in 15 mL Oral Solution) / 1 nighttime (diphenhydrAMINE hydrochloride 12.5 MG in 15 mL Oral Solution) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2685490 | 1 daytime (dextromethorphan HBr 10 MG / guaiFENesin 200 MG in 15 mL Oral Solution) / 1 nighttime (diphenhydrAMINE hydrochloride 12.5 MG in 15 mL Oral Solution) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2685490 | 1 daytime (dextromethorphan HBr 10 MG / guaiFENesin 200 MG in 15 mL Oral Solution) / 1 nighttime (diphenhydrAMINE hydrochloride 12.5 MG in 15 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2685535 | hydrocortisone 0.5 % / lidocaine hydrochloride 3 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685535 | hydrocortisone 0.5 % / lidocaine hydrochloride 3 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685535 | hydrocortisone 0.5 % / lidocaine hydrochloride 3 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2685542 | colloidal oatmeal 1 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2685542 | colloidal oatmeal 1 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2685542 | colloidal oatmeal 1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2685611 | naloxone hydrochloride 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2685612 | naloxone hydrochloride 10 MG in 0.1 ML Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2685612 | naloxone hydrochloride 10 MG in 0.1 ML Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2685612 | naloxone hydrochloride 10 MG in 0.1 ML Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2685613 | ondansetron 24 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685613 | ondansetron 24 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2685614 | rozanolixizumab-noli 420 MG in 3 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2685614 | rozanolixizumab-noli 420 MG in 3 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685614 | rozanolixizumab-noli 420 MG in 3 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685615 | RYSTIGGO 420 MG in 3 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2685615 | RYSTIGGO 420 MG in 3 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685615 | RYSTIGGO 420 MG in 3 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685616 | rozanolixizumab-noli 560 MG in 4 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2685616 | rozanolixizumab-noli 560 MG in 4 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685616 | rozanolixizumab-noli 560 MG in 4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685617 | RYSTIGGO 560 MG in 4 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2685617 | RYSTIGGO 560 MG in 4 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685617 | RYSTIGGO 560 MG in 4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685618 | rozanolixizumab-noli 840 MG in 6 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2685618 | rozanolixizumab-noli 840 MG in 6 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685618 | rozanolixizumab-noli 840 MG in 6 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685619 | RYSTIGGO 840 MG in 6 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2685619 | RYSTIGGO 840 MG in 6 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2685619 | RYSTIGGO 840 MG in 6 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2685740 | (2-naphthyloxy)acetic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2685741 | resacetophenone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2685742 | 2-methyllactic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2686032 | Gleditsia sinensis seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2686033 | PEG-50 lanolin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2686034 | Syringa oblata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2686035 | dimenhydrinate 15 MG [Gravol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2686035 | dimenhydrinate 15 MG [Gravol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2686036 | Gravol kids 15 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2686036 | Gravol kids 15 MG Chewable Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2686036 | Gravol kids 15 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2686036 | Gravol kids 15 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2686037 | Inversedine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2686038 | atipamezole hydrochloride 5 MG/ML [Inversedine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2686039 | Inversedine Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2686040 | atipamezole Injectable Solution [Inversedine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2686042 | Inversedine 5 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2686042 | Inversedine 5 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2686042 | Inversedine 5 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2686043 | tocilizumab-aazg 180 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2686045 | tocilizumab-aazg 162 MG in 0.9 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2686045 | tocilizumab-aazg 162 MG in 0.9 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2686045 | tocilizumab-aazg 162 MG in 0.9 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2686046 | tocilizumab-aazg 180 MG/ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2686046 | tocilizumab-aazg 180 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2686047 | tocilizumab-aazg 180 MG/ML [Tyenne] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2686048 | tocilizumab Auto-Injector [Tyenne] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2686050 | Tyenne 162 MG in 0.9 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2686050 | Tyenne 162 MG in 0.9 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2686050 | Tyenne 162 MG in 0.9 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2686051 | Tyenne 180 MG/ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2686051 | Tyenne 180 MG/ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2686051 | Tyenne 180 MG/ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2686053 | tocilizumab-aazg 162 MG in 0.9 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2686053 | tocilizumab-aazg 162 MG in 0.9 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2686053 | tocilizumab-aazg 162 MG in 0.9 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2686054 | tocilizumab-aazg 180 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2686054 | tocilizumab-aazg 180 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2686055 | tocilizumab Prefilled Syringe [Tyenne] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2686057 | Tyenne 162 MG in 0.9 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2686057 | Tyenne 162 MG in 0.9 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2686057 | Tyenne 162 MG in 0.9 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2686058 | Tyenne 180 MG/ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2686058 | Tyenne 180 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2686058 | Tyenne 180 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2686059 | tralokinumab Auto-Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2686061 | tralokinumab-ldrm 300 MG in 2 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2686061 | tralokinumab-ldrm 300 MG in 2 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2686061 | tralokinumab-ldrm 300 MG in 2 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2686062 | tralokinumab-ldrm 150 MG/ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2686062 | tralokinumab-ldrm 150 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2686063 | tralokinumab Auto-Injector [Adbry] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2686065 | Adbry 300 MG in 2 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2686065 | Adbry 300 MG in 2 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2686065 | Adbry 300 MG in 2 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2686066 | Adbry 150 MG/ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2686066 | Adbry 150 MG/ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2686066 | Adbry 150 MG/ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2686067 | trenbolone acetate 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2686068 | estradiol 3-benzoate 7 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2686069 | estradiol 3-benzoate 7 MG / trenbolone acetate 50 MG Drug Implant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2686069 | estradiol 3-benzoate 7 MG / trenbolone acetate 50 MG Drug Implant | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2686070 | estradiol 3-benzoate 7 MG / trenbolone acetate 50 MG [Synovex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2686071 | SYNOVEX PRIMER 50 MG / 7 MG Drug Implant | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2686071 | SYNOVEX PRIMER 50 MG / 7 MG Drug Implant | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2686071 | SYNOVEX PRIMER 50 MG / 7 MG Drug Implant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2686152 | deutetrabenazine 18 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2686153 | deutetrabenazine 18 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2686153 | deutetrabenazine 18 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2686153 | deutetrabenazine 18 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2686154 | deutetrabenazine 18 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2686155 | deutetrabenazine 18 MG [Austedo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2686156 | Austedo XR 18 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2686156 | Austedo XR 18 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2686156 | Austedo XR 18 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2686157 | deutetrabenazine 18 MG Extended Release Oral Tablet [Austedo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2686157 | deutetrabenazine 18 MG Extended Release Oral Tablet [Austedo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2686158 | ethylparaben potassium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2686166 | influenza A virus A/Thailand/8/2022 (H3N2) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2686612 | deutetrabenazine once daily pack 12 MG (7), 18 MG (7), 24 MG (7), 30 MG (7) Extended Release Oral Tablet 4 Week Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2686612 | deutetrabenazine once daily pack 12 MG (7), 18 MG (7), 24 MG (7), 30 MG (7) Extended Release Oral Tablet 4 Week Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2686612 | deutetrabenazine once daily pack 12 MG (7), 18 MG (7), 24 MG (7), 30 MG (7) Extended Release Oral Tablet 4 Week Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2686613 | Austedo XR Once Daily, 4 Week Titration Pack, 12 MG / 18 MG / 24 MG / 30 MG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2686613 | Austedo XR Once Daily, 4 Week Titration Pack, 12 MG / 18 MG / 24 MG / 30 MG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2686613 | Austedo XR Once Daily, 4 Week Titration Pack, 12 MG / 18 MG / 24 MG / 30 MG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2686619 | crovalimab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2686620 | crovalimab-akkz | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2686621 | crovalimab-akkz 170 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2686622 | crovalimab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2686623 | crovalimab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2686626 | crovalimab-akkz 340 MG in 2 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2686626 | crovalimab-akkz 340 MG in 2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2686626 | crovalimab-akkz 340 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2686627 | crovalimab-akkz 170 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2686628 | Piasky | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2686629 | crovalimab-akkz 170 MG/ML [Piasky] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2686630 | Piasky Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2686631 | crovalimab Injection [Piasky] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2686633 | Piasky 340 MG in 2 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2686633 | Piasky 340 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2686633 | Piasky 340 MG in 2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2686633 | Piasky 340 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2686634 | crovalimab-akkz 170 MG/ML Injection [Piasky] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2686634 | crovalimab-akkz 170 MG/ML Injection [Piasky] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26867 | hexocyclium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 26867 | hexocyclium | Designated preferred name (PT) | NO | |
| RxCUI: 26867 | hexocyclium | Full form of descriptor (FN) | NO | |
| RxCUI: 26867 | hexocyclium | Designated preferred name (PT) | NO | |
| RxCUI: 26867 | hexocyclium | Full form of descriptor (FN) | NO | |
| RxCUI: 2686917 | Streptococcus pneumoniae serotype 15A capsular antigen diphtheria CRM197 protein conjugate vaccine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2686918 | Streptococcus pneumoniae serotype 16F capsular antigen diphtheria CRM197 protein conjugate vaccine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2686919 | Streptococcus pneumoniae serotype 17F capsular antigen diphtheria CRM197 protein conjugate vaccine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2686920 | Streptococcus pneumoniae serotype 20A capsular antigen diphtheria CRM197 protein conjugate vaccine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2686921 | Streptococcus pneumoniae serotype 23A capsular antigen diphtheria CRM197 protein conjugate vaccine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2686922 | Streptococcus pneumoniae serotype 23B capsular antigen diphtheria CRM197 protein conjugate vaccine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2686923 | Streptococcus pneumoniae serotype 24F capsular antigen diphtheria CRM197 protein conjugate vaccine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2686924 | Streptococcus pneumoniae serotype 31 capsular antigen diphtheria CRM197 protein conjugate vaccine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2686925 | Streptococcus pneumoniae serotype 35B capsular antigen diphtheria CRM197 protein conjugate vaccine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2686926 | Streptococcus pneumoniae serotype 9N capsular antigen diphtheria CRM197 protein conjugate vaccine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2686927 | Streptococcus pneumoniae serotype 15B (de-O-acetylated) capsular antigen diphtheria CRM197 protein conjugate vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2686927 | Streptococcus pneumoniae serotype 15B (de-O-acetylated) capsular antigen diphtheria CRM197 protein conjugate vaccine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2686928 | influenza A virus A/Thailand/8/2022 (H3N2) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2686931 | influenza virus vaccine 2024-2025 (Thailand/Victoria/Austria) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2686931 | influenza virus vaccine 2024-2025 (Thailand/Victoria/Austria) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2686931 | influenza virus vaccine 2024-2025 (Thailand/Victoria/Austria) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2686932 | influenza A virus A/Thailand/8/2022 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2686933 | Fluarix 2024-2025 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2686934 | influenza A virus A/Thailand/8/2022 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML [Fluarix 2024-2025] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2686935 | Fluarix 2024-2025 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2686936 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluarix 2024-2025] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2686938 | FLUARIX 2024-2025 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2686938 | FLUARIX 2024-2025 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2686938 | FLUARIX 2024-2025 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2686939 | influenza A virus A/Thailand/8/2022 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML Prefilled Syringe [Fluarix 2024-2025] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2686940 | Flulaval 2024-2025 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2686941 | influenza A virus A/Thailand/8/2022 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML [Flulaval 2024-2025] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2686942 | Flulaval 2024-2025 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2686943 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flulaval 2024-2025] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2686945 | FLULAVAL 2024-2025 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2686945 | FLULAVAL 2024-2025 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2686945 | FLULAVAL 2024-2025 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2686946 | influenza A virus A/Thailand/8/2022 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML Prefilled Syringe [Flulaval 2024-2025] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2686947 | direct red 81 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2686948 | Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2686949 | Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2686950 | Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2686951 | Streptococcus pneumoniae serotype 8 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2686952 | Streptococcus pneumoniae serotype 9N capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2686953 | Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2686954 | Streptococcus pneumoniae serotype 11A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2686955 | Streptococcus pneumoniae serotype 12F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2686956 | Streptococcus pneumoniae serotype 15A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2686957 | Streptococcus pneumoniae serotype DEOAC15B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2686958 | Streptococcus pneumoniae serotype 16F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2686959 | Streptococcus pneumoniae serotype 17F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2686960 | Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2686961 | Streptococcus pneumoniae serotype 20A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2686962 | Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2686963 | Streptococcus pneumoniae serotype 23A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2686964 | Streptococcus pneumoniae serotype 23B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2686965 | Streptococcus pneumoniae serotype 24F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2686966 | Streptococcus pneumoniae serotype 31 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2686967 | Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2686968 | Streptococcus pneumoniae serotype 35B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2686969 | Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 11A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 12F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 15A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 16F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 17F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 20A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 24F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 31 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 35B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 8 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9N capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype DEOAC15B capsular antigen diphtheria CRM197 protein conjugate vaccine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2686970 | Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 11A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 12F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 15A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 16F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 17F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 20A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 24F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 31 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 35B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 8 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9N capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype DEOAC15B capsular antigen diphtheria CRM197 protein conjugate vaccine Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2686971 | Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 11A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 12F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 15A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 16F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 17F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 20A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 24F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 31 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 35B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 8 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9N capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype DEOAC15B capsular antigen diphtheria CRM197 protein conjugate vaccine Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2686972 | pneumococcal 21-valent conjugate vaccine (PCV21) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2686972 | pneumococcal 21-valent conjugate vaccine (PCV21) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2686972 | pneumococcal 21-valent conjugate vaccine (PCV21) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2686973 | Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 11A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 12F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 15A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 16F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 17F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 20A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 23A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 23B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 24F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 31 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 35B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 8 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 9N capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype DEOAC15B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2686974 | Capvaxive | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2686975 | Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 11A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 12F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 15A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 16F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 17F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 20A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 23A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 23B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 24F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 31 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 35B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 8 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 9N capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype DEOAC15B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML [Capvaxive] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2686976 | Capvaxive Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2686977 | Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 11A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 12F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 15A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 16F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 17F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 20A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 24F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 31 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 35B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 8 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9N capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype DEOAC15B capsular antigen diphtheria CRM197 protein conjugate vaccine Prefilled Syringe [Capvaxive] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2686978 | CAPVAXIVE vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2686978 | CAPVAXIVE vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2686978 | CAPVAXIVE vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2686979 | Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 11A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 12F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 15A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 16F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 17F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 20A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 23A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 23B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 24F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 31 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 35B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 8 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 9N capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype DEOAC15B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML Prefilled Syringe [Capvaxive] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2687204 | sotorasib 240 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2687205 | sotorasib 240 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2687205 | sotorasib 240 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2687206 | sotorasib 240 MG [Lumakras] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2687207 | LUMAKRAS 240 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2687207 | LUMAKRAS 240 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2687207 | LUMAKRAS 240 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2687211 | 1 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG in 15 mL Oral Solution) / 1 nighttime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG in 15 mL Oral Solution) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2687211 | 1 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG in 15 mL Oral Solution) / 1 nighttime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG in 15 mL Oral Solution) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2687211 | 1 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG in 15 mL Oral Solution) / 1 nighttime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG in 15 mL Oral Solution) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2687215 | ensifentrine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2687218 | ensifentrine 1.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2687219 | ensifentrine Inhalant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2687220 | ensifentrine Inhalation Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2687221 | ensifentrine 3 MG in 2.5 ML Inhalation Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2687221 | ensifentrine 3 MG in 2.5 ML Inhalation Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2687221 | ensifentrine 3 MG in 2.5 ML Inhalation Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2687222 | Ohtuvayre | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2687223 | ensifentrine 1.2 MG/ML [Ohtuvayre] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2687224 | Ohtuvayre Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2687225 | ensifentrine Inhalation Suspension [Ohtuvayre] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2687226 | Ohtuvayre 3 MG in 2.5 ML Inhalation Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2687226 | Ohtuvayre 3 MG in 2.5 ML Inhalation Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2687226 | Ohtuvayre 3 MG in 2.5 ML Inhalation Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2687236 | Amomum subulatum fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2687239 | chilipepper rockfish, cooked | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2687278 | Lysosomal alpha-glucosidase | Designated preferred name (PT) | NO | |
| RxCUI: 2687278 | Lysosomal alpha-glucosidase | Full form of descriptor (FN) | NO | |
| RxCUI: 2687278 | Lysosomal alpha-glucosidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2687282 | Lipancreatin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2687283 | Pancrelipase | Designated preferred name (PT) | NO | |
| RxCUI: 2687283 | Pancrelipase | Full form of descriptor (FN) | NO | |
| RxCUI: 2687283 | Pancrelipase | Designated preferred name (PT) | NO | |
| RxCUI: 2687283 | Pancrelipase | Full form of descriptor (FN) | NO | |
| RxCUI: 2687289 | tadalafil Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2687290 | tadalafil Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2687291 | tadalafil 10 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2687291 | tadalafil 10 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2687292 | Chewtadzy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2687293 | tadalafil 10 MG [Chewtadzy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2687294 | Chewtadzy Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2687295 | Chewtadzy Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2687296 | Chewtadzy Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2687297 | tadalafil Chewable Tablet [Chewtadzy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2687298 | CHEWTADZY 10 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2687298 | CHEWTADZY 10 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2687298 | CHEWTADZY 10 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2687299 | tadalafil 20 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2687299 | tadalafil 20 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2687300 | tadalafil 20 MG [Chewtadzy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2687301 | CHEWTADZY 20 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2687301 | CHEWTADZY 20 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2687301 | CHEWTADZY 20 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2687302 | tadalafil 5 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2687302 | tadalafil 5 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2687303 | tadalafil 5 MG [Chewtadzy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2687304 | CHEWTADZY 5 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2687304 | CHEWTADZY 5 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2687304 | CHEWTADZY 5 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2687359 | Fluad 2024-2025 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2687360 | influenza A virus A/Thailand/8/2022 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML [Fluad 2024-2025] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2687361 | Fluad 2024-2025 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2687362 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluad 2024-2025] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2687364 | FLUAD 2024-2025 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2687364 | FLUAD 2024-2025 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2687364 | FLUAD 2024-2025 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2687365 | influenza A virus A/Thailand/8/2022 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML Prefilled Syringe [Fluad 2024-2025] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2687464 | Bougainvillea glabra flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 268769 | Dimemorfan phosphate | Designated preferred name (PT) | NO | |
| RxCUI: 268769 | Dimemorfan phosphate | Full form of descriptor (FN) | NO | |
| RxCUI: 2687694 | hydrocortisone acetate 1 % / lidocaine hydrochloride 3.88 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2687694 | hydrocortisone acetate 1 % / lidocaine hydrochloride 3.88 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2687694 | hydrocortisone acetate 1 % / lidocaine hydrochloride 3.88 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2687696 | methimazole 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2687696 | methimazole 5 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2687697 | methimazole Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2687697 | methimazole Oral Liquid Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2687698 | methimazole Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2687698 | methimazole Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2687699 | methIMAzole 5 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2687699 | methIMAzole 5 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2687699 | methIMAzole 5 MG in 1 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2687699 | methIMAzole 5 MG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2687699 | methIMAzole 5 MG in 1 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 26877 | Hexyl nicotinate | Designated preferred name (PT) | NO | |
| RxCUI: 26877 | Hexyl nicotinate | Full form of descriptor (FN) | NO | |
| RxCUI: 2687700 | Felanorm | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2687701 | methimazole 5 MG/ML [Felanorm] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2687701 | methimazole 5 MG/ML [Felanorm] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2687702 | Felanorm Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2687703 | Felanorm Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2687704 | methimazole Oral Solution [Felanorm] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2687704 | methimazole Oral Solution [Felanorm] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2687705 | Felanorm 5 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2687705 | Felanorm 5 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2687705 | Felanorm 5 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2687705 | Felanorm 5 MG in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2687705 | Felanorm 5 MG in 1 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2687709 | roflumilast 1.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2687710 | roflumilast 0.15 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2687710 | roflumilast 0.15 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2687710 | roflumilast 0.15 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2687711 | roflumilast 1.5 MG/ML [Zoryve] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2687712 | ZORYVE 0.15 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2687712 | ZORYVE 0.15 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2687712 | ZORYVE 0.15 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2687712 | ZORYVE 0.15 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2687714 | influenza A virus A/Massachusetts/18/2022 (H3N2) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2687719 | influenza A virus A/California/122/2022 (H3N2) antigen 0.12 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2687722 | influenza virus vaccine 2024-2025 high-dose (trivalent - California/Victoria/Michigan) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2687722 | influenza virus vaccine 2024-2025 high-dose (trivalent - California/Victoria/Michigan) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2687722 | influenza virus vaccine 2024-2025 high-dose (trivalent - California/Victoria/Michigan) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2687723 | influenza virus vaccine 2024-2025 high-dose (trivalent - California/Victoria/Michigan) Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2687723 | influenza virus vaccine 2024-2025 high-dose (trivalent - California/Victoria/Michigan) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2687723 | influenza virus vaccine 2024-2025 high-dose (trivalent - California/Victoria/Michigan) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2687724 | Fluzone 2024-2025 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2687725 | influenza A virus A/California/122/2022 (H3N2) antigen 0.12 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.12 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.12 MG/ML [Fluzone 2024-2025] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2687726 | Fluzone 2024-2025 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2687727 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone 2024-2025] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2687729 | Fluzone 2024-2025 high-dose vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2687729 | Fluzone 2024-2025 high-dose vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2687729 | Fluzone 2024-2025 high-dose vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2687730 | Fluzone 2024-2025 high-dose vaccine Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2687730 | Fluzone 2024-2025 high-dose vaccine Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2687730 | Fluzone 2024-2025 high-dose vaccine Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2687732 | influenza A virus A/Massachusetts/18/2022 (H3N2) antigen 0.09 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2687735 | influenza virus vaccine 2024-2025 (trivalent - Massachusetts/West Virginia/Austria) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2687735 | influenza virus vaccine 2024-2025 (trivalent - Massachusetts/West Virginia/Austria) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2687735 | influenza virus vaccine 2024-2025 (trivalent - Massachusetts/West Virginia/Austria) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2687736 | influenza virus vaccine 2024-2025 (trivalent - Massachusetts/West Virginia/Austria) Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2687736 | influenza virus vaccine 2024-2025 (trivalent - Massachusetts/West Virginia/Austria) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2687736 | influenza virus vaccine 2024-2025 (trivalent - Massachusetts/West Virginia/Austria) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2687737 | Flublok 2024-2025 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2687738 | influenza A virus A/Massachusetts/18/2022 (H3N2) antigen 0.09 MG/ML / influenza A virus A/West Virginia/30/2022 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.09 MG/ML [Flublok 2024-2025] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2687739 | Flublok 2024-2025 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2687740 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flublok 2024-2025] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2687742 | Flublok 2024-2025 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2687742 | Flublok 2024-2025 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2687742 | Flublok 2024-2025 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2687743 | Flublok 2024-2025 vaccine Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2687743 | Flublok 2024-2025 vaccine Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2687743 | Flublok 2024-2025 vaccine Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 26879 | Hexylcaine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 26879 | Hexylcaine | Designated preferred name (PT) | NO | |
| RxCUI: 26879 | Hexylcaine | Full form of descriptor (FN) | NO | |
| RxCUI: 2687965 | donanemab-azbt | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2687966 | donanemab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2687967 | donanemab-azbt 17.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2687968 | donanemab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2687969 | donanemab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2687972 | donanemab-azbt 350 MG in 20 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2687972 | donanemab-azbt 350 MG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2687972 | donanemab-azbt 350 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2687973 | donanemab-azbt 17.5 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2687973 | donanemab-azbt 17.5 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2687974 | Kisunla | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2687975 | donanemab-azbt 17.5 MG/ML [Kisunla] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2687976 | Kisunla Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2687977 | donanemab Injection [Kisunla] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2687979 | kisunla 350 MG in 20 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2687979 | kisunla 350 MG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2687979 | kisunla 350 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2687980 | kisunla 17.5 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2687980 | kisunla 17.5 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2687980 | kisunla 17.5 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688015 | cupric chloride Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2688017 | cupric chloride 1.07 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2688018 | Galectin-3 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2688018 | Galectin-3 | Designated preferred name (PT) | YES | |
| RxCUI: 2688018 | Galectin-3 | Full form of descriptor (FN) | YES | |
| RxCUI: 2688020 | sodium hydrolyzed potato starch dodecenylsuccinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2688021 | camphor 105 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2688022 | camphor / lidocaine Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2688023 | camphor 10.5 % / lidocaine 4 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2688023 | camphor 10.5 % / lidocaine 4 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688023 | camphor 10.5 % / lidocaine 4 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2688024 | camphor 10 % / menthol 8 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2688024 | camphor 10 % / menthol 8 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688024 | camphor 10 % / menthol 8 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2688025 | salicylic acid 1 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2688025 | salicylic acid 1 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2688025 | salicylic acid 1 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688049 | influenza virus vaccine 2024-2025 (trivalent - California/Victoria/Michigan) Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2688049 | influenza virus vaccine 2024-2025 (trivalent - California/Victoria/Michigan) Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2688049 | influenza virus vaccine 2024-2025 (trivalent - California/Victoria/Michigan) Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2688050 | influenza A virus A/California/122/2022 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML [Fluzone 2024-2025] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2688051 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone 2024-2025] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2688053 | Fluzone 2024-2025 trivalent vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2688053 | Fluzone 2024-2025 trivalent vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2688053 | Fluzone 2024-2025 trivalent vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2688054 | influenza virus vaccine 2024-2025 (trivalent - California/Victoria/Michigan) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2688054 | influenza virus vaccine 2024-2025 (trivalent - California/Victoria/Michigan) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2688054 | influenza virus vaccine 2024-2025 (trivalent - California/Victoria/Michigan) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2688055 | influenza virus vaccine 2024-2025 (trivalent - California/Victoria/Michigan) Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2688055 | influenza virus vaccine 2024-2025 (trivalent - California/Victoria/Michigan) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2688055 | influenza virus vaccine 2024-2025 (trivalent - California/Victoria/Michigan) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688056 | Fluzone 2024-2025 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2688056 | Fluzone 2024-2025 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2688056 | Fluzone 2024-2025 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2688057 | Fluzone 2024-2025 vaccine Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2688057 | Fluzone 2024-2025 vaccine Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688057 | Fluzone 2024-2025 vaccine Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2688106 | Afluria 2024-2025 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2688107 | influenza A virus A/Thailand/8/2022 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML [Afluria 2024-2025] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2688108 | Afluria 2024-2025 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2688109 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Afluria 2024-2025] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2688111 | afluria 2024-2025 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2688111 | afluria 2024-2025 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2688111 | afluria 2024-2025 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2688112 | afluria 2024-2025 vaccine Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2688112 | afluria 2024-2025 vaccine Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688112 | afluria 2024-2025 vaccine Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2688113 | influenza A virus A/Sydney/1304/2022 (H3N2) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2688115 | influenza virus vaccine 2024-2025 (trivalent - Thailand/Victoria/Austria) Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2688115 | influenza virus vaccine 2024-2025 (trivalent - Thailand/Victoria/Austria) Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2688115 | influenza virus vaccine 2024-2025 (trivalent - Thailand/Victoria/Austria) Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2688116 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria 2024-2025] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2688118 | afluria 2024-2025 vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2688118 | afluria 2024-2025 vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2688118 | afluria 2024-2025 vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2688120 | influenza A virus A/Sydney/1304/2022 (H3N2) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2688123 | influenza virus vaccine 2024-2025 (trivalent - Georgia/Sydney/Singapore) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2688123 | influenza virus vaccine 2024-2025 (trivalent - Georgia/Sydney/Singapore) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2688123 | influenza virus vaccine 2024-2025 (trivalent - Georgia/Sydney/Singapore) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2688124 | influenza virus vaccine 2024-2025 (trivalent - Georgia/Sydney/Singapore) Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2688124 | influenza virus vaccine 2024-2025 (trivalent - Georgia/Sydney/Singapore) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2688124 | influenza virus vaccine 2024-2025 (trivalent - Georgia/Sydney/Singapore) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688125 | Flucelvax 2024-2025 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2688126 | influenza A virus A/Georgia/12/2022 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Sydney/1304/2022 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML [Flucelvax 2024-2025] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2688127 | Flucelvax 2024-2025 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2688128 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flucelvax 2024-2025] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2688130 | FLUCELVAX 2024-2025 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2688130 | FLUCELVAX 2024-2025 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2688130 | FLUCELVAX 2024-2025 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2688131 | FLUCELVAX 2024-2025 vaccine Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2688131 | FLUCELVAX 2024-2025 vaccine Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688131 | FLUCELVAX 2024-2025 vaccine Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2688133 | influenza virus vaccine 2024-2025 (trivalent - Georgia/Sydney/Singapore) Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2688133 | influenza virus vaccine 2024-2025 (trivalent - Georgia/Sydney/Singapore) Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2688133 | influenza virus vaccine 2024-2025 (trivalent - Georgia/Sydney/Singapore) Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2688134 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flucelvax 2024-2025] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2688136 | FLUCELVAX 2024-2025 vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2688136 | FLUCELVAX 2024-2025 vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2688136 | FLUCELVAX 2024-2025 vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2688287 | salicylic acid 15 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2688287 | salicylic acid 15 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2688287 | salicylic acid 15 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688454 | Inula racemosa root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2688458 | camphor 6 % / menthol 1.9 % / methyl salicylate 10 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2688458 | camphor 6 % / menthol 1.9 % / methyl salicylate 10 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2688458 | camphor 6 % / menthol 1.9 % / methyl salicylate 10 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688460 | cucurbitacin B | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2688461 | diclofenac / methyl salicylate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2688462 | diclofenac / methyl salicylate Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2688463 | diclofenac / methyl salicylate Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2688466 | diclofenac sodium 1.25 % / methyl salicylate 5 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2688466 | diclofenac sodium 1.25 % / methyl salicylate 5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2688466 | diclofenac sodium 1.25 % / methyl salicylate 5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688538 | capsaicin 0.002 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2688539 | camphor 10 % / capsaicin 0.2 % / menthol 15 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2688539 | camphor 10 % / capsaicin 0.2 % / menthol 15 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2688539 | camphor 10 % / capsaicin 0.2 % / menthol 15 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688626 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2705 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2688630 | Esomeprazole magnesium trihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2688630 | Esomeprazole magnesium trihydrate | Designated preferred name (PT) | YES | |
| RxCUI: 2688630 | Esomeprazole magnesium trihydrate | Full form of descriptor (FN) | YES | |
| RxCUI: 2688631 | vancomycin 1750 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2688632 | vancomycin 1.75 GM Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2688632 | vancomycin 1.75 GM Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2688632 | vancomycin 1.75 GM Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2688633 | vancomycin 2000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2688634 | vancomycin 2 GM Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2688634 | vancomycin 2 GM Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2688634 | vancomycin 2 GM Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2688685 | Fluzone Quadrivalent 2024-2025 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2688686 | influenza A virus A/California/122/2022 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone Quadrivalent 2024-2025] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2688687 | Fluzone Quadrivalent 2024-2025 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2688688 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2024-2025] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2688690 | Fluzone Quadrivalent 2024-2025 vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2688690 | Fluzone Quadrivalent 2024-2025 vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688690 | Fluzone Quadrivalent 2024-2025 vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2688698 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2024-2025] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2688700 | Fluzone Quadrivalent 2024-2025 vaccine 0.5 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2688700 | Fluzone Quadrivalent 2024-2025 vaccine 0.5 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2688700 | Fluzone Quadrivalent 2024-2025 vaccine 0.5 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688701 | influenza A virus A/California/122/2022 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2024-2025] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 268872 | Prednisolone metasulfobenzoate sodium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 268872 | Prednisolone metasulfobenzoate sodium | Full form of descriptor (FN) | NO | |
| RxCUI: 268872 | Prednisolone metasulfobenzoate sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 268872 | Prednisolone metasulfobenzoate sodium | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 268872 | Prednisolone metasulfobenzoate sodium | Designated preferred name (PT) | NO | |
| RxCUI: 2688819 | adalimumab-ryvk 20 MG in 0.2 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2688819 | adalimumab-ryvk 20 MG in 0.2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2688819 | adalimumab-ryvk 20 MG in 0.2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2688820 | adalimumab-ryvk 100 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2688820 | adalimumab-ryvk 100 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2688821 | adalimumab Prefilled Syringe [Simlandi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2688823 | Simlandi 20 MG in 0.2 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2688823 | Simlandi 20 MG in 0.2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2688823 | Simlandi 20 MG in 0.2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2688824 | Simlandi 100 MG/ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2688824 | Simlandi 100 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2688824 | Simlandi 100 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688826 | adalimumab-ryvk 40 MG in 0.4 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2688826 | adalimumab-ryvk 40 MG in 0.4 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2688826 | adalimumab-ryvk 40 MG in 0.4 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2688827 | Simlandi 40 MG in 0.4 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2688827 | Simlandi 40 MG in 0.4 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2688827 | Simlandi 40 MG in 0.4 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2688828 | adalimumab-ryvk 80 MG in 0.8 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2688828 | adalimumab-ryvk 80 MG in 0.8 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2688828 | adalimumab-ryvk 80 MG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2688829 | Simlandi 80 MG in 0.8 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2688829 | Simlandi 80 MG in 0.8 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2688829 | Simlandi 80 MG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2688830 | influenza A virus A/California/122/2022 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML [Fluzone Quadrivalent 2024-2025] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2688831 | Fluzone Quadrivalent 2024-2025 high dose vaccine 0.7 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2688831 | Fluzone Quadrivalent 2024-2025 high dose vaccine 0.7 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2688831 | Fluzone Quadrivalent 2024-2025 high dose vaccine 0.7 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688832 | Fluzone Quadrivalent 2024-2025 high dose vaccine Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2688832 | Fluzone Quadrivalent 2024-2025 high dose vaccine Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688832 | Fluzone Quadrivalent 2024-2025 high dose vaccine Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2688833 | Posfrea | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2688834 | palonosetron 0.05 MG/ML [Posfrea] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2688835 | Posfrea Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2688836 | palonosetron Injection [Posfrea] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2688837 | Posfrea 0.075 MG in 1.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2688837 | Posfrea 0.075 MG in 1.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2688837 | Posfrea 0.075 MG in 1.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688838 | Posfrea 0.05 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2688838 | Posfrea 0.05 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2688838 | Posfrea 0.05 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688839 | Posfrea 0.25 MG in 5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2688839 | Posfrea 0.25 MG in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2688839 | Posfrea 0.25 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2688858 | Aspirin and caffeine only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688858 | Aspirin and caffeine only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688859 | Cetalkonium and choline salicylate only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688859 | Cetalkonium and choline salicylate only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688860 | Cetalkonium and choline salicylate only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688860 | Cetalkonium and choline salicylate only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688861 | Cetylpyridinium and chlorocresol and lidocaine only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688861 | Cetylpyridinium and chlorocresol and lidocaine only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688862 | Cetylpyridinium and chlorocresol and lidocaine only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688862 | Cetylpyridinium and chlorocresol and lidocaine only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688863 | Dibasic sodium phosphate and monobasic sodium phosphate only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688863 | Dibasic sodium phosphate and monobasic sodium phosphate only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688864 | Dibasic sodium phosphate and monobasic sodium phosphate only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688864 | Dibasic sodium phosphate and monobasic sodium phosphate only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688865 | Diphenhydramine and levomenthol only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688865 | Diphenhydramine and levomenthol only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688866 | Dydrogesterone and estradiol only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688866 | Dydrogesterone and estradiol only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688867 | Brompheniramine and caffeine and paracetamol only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688867 | Brompheniramine and caffeine and paracetamol only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688867 | Brompheniramine and caffeine and paracetamol only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688868 | Brompheniramine and caffeine and paracetamol only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688868 | Brompheniramine and caffeine and paracetamol only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688868 | Brompheniramine and caffeine and paracetamol only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688869 | Buclizine and codeine and paracetamol only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688869 | Buclizine and codeine and paracetamol only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688869 | Buclizine and codeine and paracetamol only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688870 | Buclizine and codeine and paracetamol only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688870 | Buclizine and codeine and paracetamol only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688870 | Buclizine and codeine and paracetamol only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688871 | Diphenhydramine and paracetamol and pseudoephedrine only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688871 | Diphenhydramine and paracetamol and pseudoephedrine only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688871 | Diphenhydramine and paracetamol and pseudoephedrine only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688872 | Diphenhydramine and paracetamol and pseudoephedrine only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688872 | Diphenhydramine and paracetamol and pseudoephedrine only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688872 | Diphenhydramine and paracetamol and pseudoephedrine only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688873 | Ibuprofen and paracetamol only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688873 | Ibuprofen and paracetamol only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688873 | Ibuprofen and paracetamol only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688874 | Balsam of Peru and bismuth oxide and zinc oxide only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688874 | Balsam of Peru and bismuth oxide and zinc oxide only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688875 | Balsam of Peru and bismuth oxide and zinc oxide only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688875 | Balsam of Peru and bismuth oxide and zinc oxide only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688876 | Benzocaine only product in gingival dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688876 | Benzocaine only product in gingival dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688877 | Benzydamine and cetylpyridinium only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688877 | Benzydamine and cetylpyridinium only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688878 | Benzydamine and cetylpyridinium only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688878 | Benzydamine and cetylpyridinium only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688879 | Chlorhexidine and lidocaine only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688879 | Chlorhexidine and lidocaine only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688880 | Empagliflozin and linagliptin only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688880 | Empagliflozin and linagliptin only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688881 | Emtricitabine and rilpivirine and tenofovir only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688881 | Emtricitabine and rilpivirine and tenofovir only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688882 | Enalapril and lercanidipine only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688882 | Enalapril and lercanidipine only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688883 | Enalapril and lercanidipine only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688883 | Enalapril and lercanidipine only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688884 | Aluminium hydroxide and magnesium hydroxide and simeticone only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688884 | Aluminium hydroxide and magnesium hydroxide and simeticone only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688884 | Aluminium hydroxide and magnesium hydroxide and simeticone only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688885 | Aminoacridine and lidocaine only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688885 | Aminoacridine and lidocaine only product in oromucosal dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688885 | Aminoacridine and lidocaine only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688886 | Bimekizumab only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688886 | Bimekizumab only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688887 | Bimekizumab only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688887 | Bimekizumab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688888 | Brimonidine and brinzolamide only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688888 | Brimonidine and brinzolamide only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688889 | Ertugliflozin and sitagliptin only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688889 | Ertugliflozin and sitagliptin only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688890 | Ertugliflozin and sitagliptin only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688890 | Ertugliflozin and sitagliptin only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688891 | Amlodipine and atorvastatin and perindopril only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688891 | Amlodipine and atorvastatin and perindopril only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688892 | Amlodipine and atorvastatin and perindopril only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688892 | Amlodipine and atorvastatin and perindopril only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688893 | Amlodipine and indapamide and perindopril only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688893 | Amlodipine and indapamide and perindopril only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688894 | Brimonidine and brinzolamide only product in ocular dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688894 | Brimonidine and brinzolamide only product in ocular dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688895 | Brinzolamide and timolol only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688895 | Brinzolamide and timolol only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688896 | Brinzolamide and timolol only product in ocular dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688896 | Brinzolamide and timolol only product in ocular dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688897 | Dapagliflozin and metformin only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688897 | Dapagliflozin and metformin only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688898 | Dapagliflozin and metformin only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688898 | Dapagliflozin and metformin only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688899 | Dapagliflozin and saxagliptin only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688899 | Dapagliflozin and saxagliptin only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688900 | Fluorouracil and salicylic acid only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688900 | Fluorouracil and salicylic acid only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688901 | Fluorouracil and salicylic acid only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688901 | Fluorouracil and salicylic acid only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688902 | Foscarbidopa and foslevodopa only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688902 | Foscarbidopa and foslevodopa only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688903 | Foscarbidopa and foslevodopa only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688903 | Foscarbidopa and foslevodopa only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688904 | Inclisiran only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688904 | Inclisiran only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688905 | Inclisiran only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688905 | Inclisiran only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688906 | Amlodipine and indapamide and perindopril only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688906 | Amlodipine and indapamide and perindopril only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688907 | Amylmetacresol and dichlorobenzyl alcohol and lidocaine only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688907 | Amylmetacresol and dichlorobenzyl alcohol and lidocaine only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688908 | Amylmetacresol and dichlorobenzyl alcohol and lidocaine only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688908 | Amylmetacresol and dichlorobenzyl alcohol and lidocaine only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688909 | Guaifenesin and levomenthol only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688909 | Guaifenesin and levomenthol only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688910 | Guaifenesin and levomenthol only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688910 | Guaifenesin and levomenthol only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688911 | Hepatitis B recombinant surface antigen only vaccine product | Designated preferred name (PT) | NO | |
| RxCUI: 2688911 | Hepatitis B recombinant surface antigen only vaccine product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688912 | Ascorbic acid and zinc citrate only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688912 | Ascorbic acid and zinc citrate only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688913 | Ascorbic acid and zinc citrate only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688913 | Ascorbic acid and zinc citrate only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688914 | Calcium chloride and glucose and potassium chloride and sodium chloride and sodium lactate only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688914 | Calcium chloride and glucose and potassium chloride and sodium chloride and sodium lactate only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688915 | Calcium gluconate and colecalciferol and nicotinic acid only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688915 | Calcium gluconate and colecalciferol and nicotinic acid only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688915 | Calcium gluconate and colecalciferol and nicotinic acid only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688916 | Calcium gluconate and colecalciferol and nicotinic acid only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688916 | Calcium gluconate and colecalciferol and nicotinic acid only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688916 | Calcium gluconate and colecalciferol and nicotinic acid only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688917 | Dapagliflozin and saxagliptin only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688917 | Dapagliflozin and saxagliptin only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688918 | Dexketoprofen and tramadol only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688918 | Dexketoprofen and tramadol only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688919 | Dexketoprofen and tramadol only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688919 | Dexketoprofen and tramadol only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688920 | Dextromethorphan and diphenhydramine and levomenthol only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688920 | Dextromethorphan and diphenhydramine and levomenthol only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688921 | Dextromethorphan and diphenhydramine and levomenthol only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688921 | Dextromethorphan and diphenhydramine and levomenthol only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688922 | Dextromethorphan and pseudoephedrine and triprolidine only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688922 | Dextromethorphan and pseudoephedrine and triprolidine only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688923 | Dextromethorphan and pseudoephedrine and triprolidine only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688923 | Dextromethorphan and pseudoephedrine and triprolidine only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688924 | Perhexiline only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688924 | Perhexiline only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688925 | Pertuzumab and trastuzumab only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688925 | Pertuzumab and trastuzumab only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688926 | Pertuzumab and trastuzumab only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688926 | Pertuzumab and trastuzumab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688927 | Povidone iodine only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688927 | Povidone iodine only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688928 | Product containing only ripasudil (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2688928 | Product containing only ripasudil (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2688929 | Product containing only ripasudil in ocular dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2688929 | Product containing only ripasudil in ocular dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2688930 | Product containing only tafluprost and timolol (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2688930 | Product containing only tafluprost and timolol (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2688931 | Product containing only tafluprost and timolol in ocular dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2688931 | Product containing only tafluprost and timolol in ocular dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2688932 | Product containing only tezepelumab (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2688932 | Product containing only tezepelumab (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2688933 | Product containing only tezepelumab in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2688933 | Product containing only tezepelumab in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2688934 | Product containing only tralokinumab (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2688934 | Product containing only tralokinumab (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2688935 | Product containing only tralokinumab in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2688935 | Product containing only tralokinumab in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2688936 | Product containing only trofosfamide (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2688936 | Product containing only trofosfamide (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2688937 | Product containing only trofosfamide in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2688937 | Product containing only trofosfamide in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2688938 | Lauromacrogol 400 only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688938 | Lauromacrogol 400 only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688939 | Lidocaine and naphazoline only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688939 | Lidocaine and naphazoline only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688940 | Lidocaine and naphazoline only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688940 | Lidocaine and naphazoline only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688941 | Chlormethine only product in cutaneous dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688941 | Chlormethine only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688941 | Chlormethine only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688942 | Neisseria meningitidis serogroup A capsular polysaccharide conjugated antigen only vaccine product | Designated preferred name (PT) | NO | |
| RxCUI: 2688942 | Neisseria meningitidis serogroup A capsular polysaccharide conjugated antigen only vaccine product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688943 | Nirmatrelvir only product | Designated preferred name (PT) | NO | |
| RxCUI: 2688943 | Nirmatrelvir only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688944 | Nirmatrelvir only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688944 | Nirmatrelvir only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2688945 | dibasic potassium phosphate 4.72 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2688946 | monobasic potassium phosphate 4.48 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2688947 | potassium phosphates (phosphorus 15 MMOL / potassium 22 MEQ) in 250 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2688947 | potassium phosphates (phosphorus 15 MMOL / potassium 22 MEQ) in 250 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2688947 | potassium phosphates (phosphorus 15 MMOL / potassium 22 MEQ) in 250 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2688947 | potassium phosphates (phosphorus 15 MMOL / potassium 22 MEQ) in 250 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2688947 | potassium phosphates (phosphorus 15 MMOL / potassium 22 MEQ) in 250 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2688948 | dibasic K+ phosphate 4.72 MG/ML / monobasic K+ phosphate 4.48 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688948 | dibasic K+ phosphate 4.72 MG/ML / monobasic K+ phosphate 4.48 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2688948 | dibasic K+ phosphate 4.72 MG/ML / monobasic K+ phosphate 4.48 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2688949 | Amlodipine- and atorvastatin- and perindopril-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2688949 | Amlodipine- and atorvastatin- and perindopril-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2688950 | Amlodipine- and atorvastatin- and perindopril-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2688950 | Amlodipine- and atorvastatin- and perindopril-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2689049 | Amlodipine (as amlodipine besilate) 10 mg and atorvastatin (as atorvastatin calcium) 20 mg and perindopril arginine 10 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689049 | Amlodipine (as amlodipine besilate) 10 mg and atorvastatin (as atorvastatin calcium) 20 mg and perindopril arginine 10 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689049 | Amlodipine (as amlodipine besilate) 10 mg and atorvastatin (as atorvastatin calcium) 20 mg and perindopril arginine 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689050 | Amlodipine (as amlodipine besilate) 10 mg and indapamide 2.5 mg and perindopril arginine 10 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689050 | Amlodipine (as amlodipine besilate) 10 mg and indapamide 2.5 mg and perindopril arginine 10 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689050 | Amlodipine (as amlodipine besilate) 10 mg and indapamide 2.5 mg and perindopril arginine 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689051 | Canagliflozin 150 mg and metformin hydrochloride 850 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689051 | Canagliflozin 150 mg and metformin hydrochloride 850 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689052 | Canagliflozin 50 mg and metformin hydrochloride 850 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689052 | Canagliflozin 50 mg and metformin hydrochloride 850 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689053 | Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689053 | Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689055 | Pegvaliase 10 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2689055 | Pegvaliase 10 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2689056 | Pegvaliase 2.5 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2689056 | Pegvaliase 2.5 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2689057 | Pegvaliase 20 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2689057 | Pegvaliase 20 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2689058 | Perindopril arginine 2.5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689058 | Perindopril arginine 2.5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689059 | Pertuzumab 60 mg/mL and trastuzumab 60 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2689059 | Pertuzumab 60 mg/mL and trastuzumab 60 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2689060 | Pertuzumab 80 mg/mL and trastuzumab 40 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2689060 | Pertuzumab 80 mg/mL and trastuzumab 40 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2689061 | Pertuzumab- and trastuzumab-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2689061 | Pertuzumab- and trastuzumab-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2689062 | Product containing precisely remimazolam (as remimazolam besylate) 50 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2689062 | Product containing precisely remimazolam (as remimazolam besylate) 50 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2689063 | Product containing precisely remimazolam (as remimazolam besylate) 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2689063 | Product containing precisely remimazolam (as remimazolam besylate) 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2689064 | Product containing precisely remimazolam (as remimazolam besylate) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2689064 | Product containing precisely remimazolam (as remimazolam besylate) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2689066 | Povidone iodine 4.5 mg/g oromucosal spray | Designated preferred name (PT) | NO | |
| RxCUI: 2689066 | Povidone iodine 4.5 mg/g oromucosal spray | Full form of descriptor (FN) | NO | |
| RxCUI: 2689067 | Belimumab 200 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2689067 | Belimumab 200 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2689068 | Bimekizumab 160 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2689068 | Bimekizumab 160 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2689069 | Pertuzumab- and trastuzumab-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2689069 | Pertuzumab- and trastuzumab-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 268907 | acetoxolone aluminum | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2689070 | Product containing precisely tezepelumab 110 milligram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2689070 | Product containing precisely tezepelumab 110 milligram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2689071 | Product containing precisely ripasudil (as ripasudil hydrochloride) 4 milligram/1 milliliter conventional release solution for eye drops (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2689071 | Product containing precisely ripasudil (as ripasudil hydrochloride) 4 milligram/1 milliliter conventional release solution for eye drops (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2689072 | Ripasudil hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 2689072 | Ripasudil hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 2689073 | Indapamide 2.5 mg and perindopril tosilate 10 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689073 | Indapamide 2.5 mg and perindopril tosilate 10 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689073 | Indapamide 2.5 mg and perindopril tosilate 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689074 | Indapamide 625 microgram and perindopril arginine 2.5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689074 | Indapamide 625 microgram and perindopril arginine 2.5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689075 | Indapamide 625 microgram and perindopril tosilate 2.5 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689075 | Indapamide 625 microgram and perindopril tosilate 2.5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689075 | Indapamide 625 microgram and perindopril tosilate 2.5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689076 | Foscarbidopa 12 mg/mL and foslevodopa 240 mg/mL solution for infusion | Designated preferred name (PT) | NO | |
| RxCUI: 2689076 | Foscarbidopa 12 mg/mL and foslevodopa 240 mg/mL solution for infusion | Full form of descriptor (FN) | NO | |
| RxCUI: 2689077 | Foscarbidopa- and foslevodopa-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2689077 | Foscarbidopa- and foslevodopa-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2689079 | Antibody to free-living Amoeba | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689079 | Antibody to free-living Amoeba | Full form of descriptor (FN) | NO | |
| RxCUI: 2689079 | Antibody to free-living Amoeba | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689079 | Antibody to free-living Amoeba | Designated preferred name (PT) | NO | |
| RxCUI: 2689080 | Inclisiran (as inclisiran sodium) 189 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2689080 | Inclisiran (as inclisiran sodium) 189 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2689081 | Indapamide 1.25 mg and perindopril arginine 5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689081 | Indapamide 1.25 mg and perindopril arginine 5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689082 | Guaifenesin 20 mg/mL and levomenthol 220 microgram/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2689082 | Guaifenesin 20 mg/mL and levomenthol 220 microgram/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2689083 | Product containing precisely tafluprost 15 microgram/1 milliliter and timolol (as timolol maleate) 5 milligram/1 milliliter conventional release solution for eye drops (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2689083 | Product containing precisely tafluprost 15 microgram/1 milliliter and timolol (as timolol maleate) 5 milligram/1 milliliter conventional release solution for eye drops (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2689084 | Product containing tafluprost and timolol (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2689084 | Product containing tafluprost and timolol (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2689085 | Product containing tafluprost and timolol in ocular dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2689085 | Product containing tafluprost and timolol in ocular dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2689086 | Tapentadol maleate hemihydrate | Designated preferred name (PT) | NO | |
| RxCUI: 2689086 | Tapentadol maleate hemihydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 2689087 | Product containing precisely zonisamide 25 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2689087 | Product containing precisely zonisamide 25 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2689088 | Carbidopa anhydrous (as carbidopa) 43.75 mg and entacapone 200 mg and levodopa 175 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689088 | Carbidopa anhydrous (as carbidopa) 43.75 mg and entacapone 200 mg and levodopa 175 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689089 | Capillary plasma | Designated preferred name (PT) | NO | |
| RxCUI: 2689089 | Capillary plasma | Full form of descriptor (FN) | NO | |
| RxCUI: 2689090 | Capillary serum | Designated preferred name (PT) | NO | |
| RxCUI: 2689090 | Capillary serum | Full form of descriptor (FN) | NO | |
| RxCUI: 2689091 | Cetylpyridinium- and chlorocresol- and lidocaine-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2689091 | Cetylpyridinium- and chlorocresol- and lidocaine-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2689092 | Benidipine hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 2689092 | Benidipine hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 2689093 | Buclizine- and codeine- and paracetamol-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2689093 | Buclizine- and codeine- and paracetamol-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689093 | Buclizine- and codeine- and paracetamol-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2689094 | Dydrogesterone 10 mg and estradiol 2 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689094 | Dydrogesterone 10 mg and estradiol 2 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689096 | Dydrogesterone 2.5 mg and estradiol 500 microgram oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689096 | Dydrogesterone 2.5 mg and estradiol 500 microgram oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689097 | Diphenhydramine hydrochloride 12.5 mg and paracetamol 500 mg and pseudoephedrine hydrochloride 22.5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689097 | Diphenhydramine hydrochloride 12.5 mg and paracetamol 500 mg and pseudoephedrine hydrochloride 22.5 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689097 | Diphenhydramine hydrochloride 12.5 mg and paracetamol 500 mg and pseudoephedrine hydrochloride 22.5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689098 | Buclizine- and codeine- and paracetamol-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2689098 | Buclizine- and codeine- and paracetamol-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689098 | Buclizine- and codeine- and paracetamol-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2689099 | Abacavir hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 2689099 | Abacavir hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 2689100 | Oxazepam 25 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689100 | Oxazepam 25 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689101 | Midazolam (as midazolam hydrochloride) 2.5 mg/actuation nasal solution spray | Designated preferred name (PT) | NO | |
| RxCUI: 2689101 | Midazolam (as midazolam hydrochloride) 2.5 mg/actuation nasal solution spray | Full form of descriptor (FN) | NO | |
| RxCUI: 2689102 | Midazolam (as midazolam hydrochloride) 5 mg/actuation nasal solution spray | Designated preferred name (PT) | NO | |
| RxCUI: 2689102 | Midazolam (as midazolam hydrochloride) 5 mg/actuation nasal solution spray | Full form of descriptor (FN) | NO | |
| RxCUI: 2689103 | Metoclopramide hydrochloride anhydrous | Designated preferred name (PT) | NO | |
| RxCUI: 2689103 | Metoclopramide hydrochloride anhydrous | Full form of descriptor (FN) | NO | |
| RxCUI: 2689104 | Metformin hydrochloride 850 mg and vildagliptin 50 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689104 | Metformin hydrochloride 850 mg and vildagliptin 50 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689108 | pitavastatin sodium 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2689112 | pitavastatin sodium 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2689112 | pitavastatin sodium 1 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2689113 | Nikita | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2689114 | pitavastatin sodium 1 MG [Nikita] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2689115 | Nikita Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2689116 | Nikita Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2689117 | pitavastatin Oral Tablet [Nikita] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2689119 | NIKITA 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2689119 | NIKITA 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2689119 | NIKITA 1 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2689120 | pitavastatin sodium 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2689121 | pitavastatin sodium 2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2689121 | pitavastatin sodium 2 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2689122 | pitavastatin sodium 2 MG [Nikita] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2689123 | NIKITA 2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2689123 | NIKITA 2 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2689123 | NIKITA 2 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2689124 | pitavastatin sodium 4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2689125 | pitavastatin sodium 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2689125 | pitavastatin sodium 4 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2689126 | pitavastatin sodium 4 MG [Nikita] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2689127 | NIKITA 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2689127 | NIKITA 4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2689127 | NIKITA 4 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2689128 | camphor 0.5 % / menthol 3 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2689128 | camphor 0.5 % / menthol 3 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689128 | camphor 0.5 % / menthol 3 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2689130 | terazosin 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2689131 | terazosin Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2689132 | terazosin Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2689133 | terazosin 1 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2689133 | terazosin 1 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2689133 | terazosin 1 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2689134 | Tezruly | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2689135 | terazosin 1 MG/ML [Tezruly] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2689136 | Tezruly Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2689137 | Tezruly Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2689138 | terazosin Oral Solution [Tezruly] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2689139 | TEZRULY 1 MG/mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2689139 | TEZRULY 1 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2689139 | TEZRULY 1 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2689139 | TEZRULY 1 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2689140 | bortezomib 2.5 MG in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2689140 | bortezomib 2.5 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2689140 | bortezomib 2.5 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689141 | methotrexate 5 GM in 50 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2689141 | methotrexate 5 GM in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689141 | methotrexate 5 GM in 50 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2689142 | methotrexate 100 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2689143 | 1,1,1,2-tetrafluorochloroethane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2689144 | Cetalkonium- and choline salicylate-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2689144 | Cetalkonium- and choline salicylate-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2689145 | Cetalkonium- and choline salicylate-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2689145 | Cetalkonium- and choline salicylate-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2689146 | Diphenhydramine- and levomenthol-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2689146 | Diphenhydramine- and levomenthol-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2689147 | Brompheniramine- and caffeine- and paracetamol-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2689147 | Brompheniramine- and caffeine- and paracetamol-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689147 | Brompheniramine- and caffeine- and paracetamol-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2689148 | Brompheniramine- and caffeine- and paracetamol-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2689148 | Brompheniramine- and caffeine- and paracetamol-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689148 | Brompheniramine- and caffeine- and paracetamol-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2689149 | Balsam of Peru- and bismuth oxide- and zinc oxide-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2689149 | Balsam of Peru- and bismuth oxide- and zinc oxide-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2689150 | Balsam of Peru- and bismuth oxide- and zinc oxide-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2689150 | Balsam of Peru- and bismuth oxide- and zinc oxide-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2689151 | Dutasteride 100 microgram/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2689151 | Dutasteride 100 microgram/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2689152 | Dextromethorphan hydrobromide 750 microgram/mL and paracetamol 50 mg/mL and promethazine hydrochloride 1 mg/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2689152 | Dextromethorphan hydrobromide 750 microgram/mL and paracetamol 50 mg/mL and promethazine hydrochloride 1 mg/mL oral solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689152 | Dextromethorphan hydrobromide 750 microgram/mL and paracetamol 50 mg/mL and promethazine hydrochloride 1 mg/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2689153 | Acetaminophen 500 mg and caffeine 30 mg and codeine phosphate 8 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689153 | Acetaminophen 500 mg and caffeine 30 mg and codeine phosphate 8 mg oral tablet | British preferred term (PTGB) | NO | |
| RxCUI: 2689153 | Acetaminophen 500 mg and caffeine 30 mg and codeine phosphate 8 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689154 | Dexketoprofen- and tramadol-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2689154 | Dexketoprofen- and tramadol-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2689155 | Dexketoprofen- and tramadol-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2689155 | Dexketoprofen- and tramadol-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2689156 | Dexketoprofen 25 mg and tramadol hydrochloride 75 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689156 | Dexketoprofen 25 mg and tramadol hydrochloride 75 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689158 | Indapamide 1.25 mg and perindopril tosilate 5 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689158 | Indapamide 1.25 mg and perindopril tosilate 5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689158 | Indapamide 1.25 mg and perindopril tosilate 5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689159 | Indapamide 2.5 mg and perindopril arginine 10 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689159 | Indapamide 2.5 mg and perindopril arginine 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689160 | Amlodipine- and indapamide- and perindopril-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2689160 | Amlodipine- and indapamide- and perindopril-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2689161 | Metformin hydrochloride 1 g and saxagliptin (as saxagliptin hydrochloride) 2.5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689161 | Metformin hydrochloride 1 g and saxagliptin (as saxagliptin hydrochloride) 2.5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689164 | Lidocaine- and naphazoline-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2689164 | Lidocaine- and naphazoline-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2689165 | Lidocaine- and naphazoline-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2689165 | Lidocaine- and naphazoline-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2689166 | Lidocaine hydrochloride anhydrous (as lidocaine hydrochloride) 50 mg/mL and naphazoline nitrate 200 microgram/mL oromucosal solution | Designated preferred name (PT) | NO | |
| RxCUI: 2689166 | Lidocaine hydrochloride anhydrous (as lidocaine hydrochloride) 50 mg/mL and naphazoline nitrate 200 microgram/mL oromucosal solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2689267 | chloroxylenol 3.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2689268 | chloroxylenol 0.35 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2689268 | chloroxylenol 0.35 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689268 | chloroxylenol 0.35 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2689269 | Cereal grain | Designated preferred name (PT) | NO | |
| RxCUI: 2689269 | Cereal grain | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689269 | Cereal grain | Full form of descriptor (FN) | NO | |
| RxCUI: 2689270 | Hydroabietyl alcohol | Designated preferred name (PT) | NO | |
| RxCUI: 2689270 | Hydroabietyl alcohol | Full form of descriptor (FN) | NO | |
| RxCUI: 2689270 | Hydroabietyl alcohol | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689271 | Diphenhydramine hydrochloride 1.4 mg/mL and levomenthol 110 microgram/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2689271 | Diphenhydramine hydrochloride 1.4 mg/mL and levomenthol 110 microgram/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2689272 | Diphenhydramine hydrochloride 2.8 mg/mL and levomenthol 220 microgram/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2689272 | Diphenhydramine hydrochloride 2.8 mg/mL and levomenthol 220 microgram/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2689273 | Ibuprofen 150 mg and paracetamol 500 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689273 | Ibuprofen 150 mg and paracetamol 500 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689273 | Ibuprofen 150 mg and paracetamol 500 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689274 | Balsam of Peru 18 mg/g and bismuth oxide 21.4 mg/g and zinc oxide 107.5 mg/g cutaneous cream | Designated preferred name (PT) | NO | |
| RxCUI: 2689274 | Balsam of Peru 18 mg/g and bismuth oxide 21.4 mg/g and zinc oxide 107.5 mg/g cutaneous cream | Full form of descriptor (FN) | NO | |
| RxCUI: 2689275 | Balsam of Peru patch test product | Designated preferred name (PT) | NO | |
| RxCUI: 2689275 | Balsam of Peru patch test product | Full form of descriptor (FN) | NO | |
| RxCUI: 2689276 | Benzocaine-containing product in gingival dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2689276 | Benzocaine-containing product in gingival dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2689277 | Chlorhexidine- and lidocaine-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2689277 | Chlorhexidine- and lidocaine-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2689278 | Colecalciferol 800 unit oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689278 | Colecalciferol 800 unit oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689278 | Colecalciferol 800 unit oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689279 | Brompheniramine maleate 3 mg and caffeine 30 mg and paracetamol 325 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689279 | Brompheniramine maleate 3 mg and caffeine 30 mg and paracetamol 325 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689279 | Brompheniramine maleate 3 mg and caffeine 30 mg and paracetamol 325 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689280 | letibotulinumtoxinA | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2689281 | Cetalkonium chloride 100 microgram/g and choline salicylate 87.14 mg/g oromucosal gel | Designated preferred name (PT) | NO | |
| RxCUI: 2689281 | Cetalkonium chloride 100 microgram/g and choline salicylate 87.14 mg/g oromucosal gel | Full form of descriptor (FN) | NO | |
| RxCUI: 2689282 | letibotulinumtoxinA-wlbg | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2689283 | Dibasic sodium phosphate 240 microgram/mL and monobasic sodium phosphate 542 microgram/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2689283 | Dibasic sodium phosphate 240 microgram/mL and monobasic sodium phosphate 542 microgram/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2689284 | Dibasic sodium phosphate- and monobasic sodium phosphate-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2689284 | Dibasic sodium phosphate- and monobasic sodium phosphate-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2689285 | Dibasic sodium phosphate-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2689285 | Dibasic sodium phosphate-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2689286 | Cetylpyridinium chloride 200 microgram/g and chlorocresol 1 mg/g and lidocaine hydrochloride 9 mg/g oromucosal solution | Designated preferred name (PT) | NO | |
| RxCUI: 2689286 | Cetylpyridinium chloride 200 microgram/g and chlorocresol 1 mg/g and lidocaine hydrochloride 9 mg/g oromucosal solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2689287 | letibotulinumtoxinA-wlbg 100 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2689290 | letibotulinumtoxinA-wlbg 100 UNT Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2689290 | letibotulinumtoxinA-wlbg 100 UNT Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2689291 | Letybo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2689292 | letibotulinumtoxinA-wlbg 100 UNT [Letybo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2689293 | Letybo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2689294 | Cetylpyridinium- and chlorocresol- and lidocaine-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2689294 | Cetylpyridinium- and chlorocresol- and lidocaine-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2689295 | botulinum toxin type A Injection [Letybo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2689297 | Letybo 100 UNT Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2689297 | Letybo 100 UNT Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2689297 | Letybo 100 UNT Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2689298 | letibotulinumtoxinA-wlbg 50 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2689299 | letibotulinumtoxinA-wlbg 50 UNT Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2689299 | letibotulinumtoxinA-wlbg 50 UNT Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2689300 | letibotulinumtoxinA-wlbg 50 UNT [Letybo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2689301 | Letybo 50 UNT Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2689301 | Letybo 50 UNT Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2689301 | Letybo 50 UNT Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2689302 | Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil maleate) 245 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689302 | Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil maleate) 245 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689303 | Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil phosphate) 245 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689303 | Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil phosphate) 245 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689304 | Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689304 | Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689305 | Empagliflozin 5 mg and metformin hydrochloride 850 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689305 | Empagliflozin 5 mg and metformin hydrochloride 850 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689306 | Emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689306 | Emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689308 | Enalapril maleate 10 mg and lercanidipine hydrochloride 10 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689308 | Enalapril maleate 10 mg and lercanidipine hydrochloride 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689309 | Enalapril maleate 20 mg and lercanidipine hydrochloride 10 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689309 | Enalapril maleate 20 mg and lercanidipine hydrochloride 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689310 | Enalapril maleate 20 mg and lercanidipine hydrochloride 20 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689310 | Enalapril maleate 20 mg and lercanidipine hydrochloride 20 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689311 | Enalapril- and lercanidipine-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2689311 | Enalapril- and lercanidipine-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2689312 | hydrocortisone acetate 1 % / lidocaine HCl 5 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2689312 | hydrocortisone acetate 1 % / lidocaine HCl 5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2689312 | hydrocortisone acetate 1 % / lidocaine HCl 5 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2689314 | Hydrochlorothiazide 25 mg and nebivolol (as nebivolol hydrochloride) 5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689314 | Hydrochlorothiazide 25 mg and nebivolol (as nebivolol hydrochloride) 5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689315 | Hydrochlorothiazide 25 mg and olmesartan medoxomil 20 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689315 | Hydrochlorothiazide 25 mg and olmesartan medoxomil 20 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689316 | Aluminium hydroxide 35 mg/mL and magnesium hydroxide 40 mg/mL and simeticone 5 mg/mL oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689316 | Aluminium hydroxide 35 mg/mL and magnesium hydroxide 40 mg/mL and simeticone 5 mg/mL oral suspension | Designated preferred name (PT) | NO | |
| RxCUI: 2689316 | Aluminium hydroxide 35 mg/mL and magnesium hydroxide 40 mg/mL and simeticone 5 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 2689317 | Aluminium hydroxide- and magnesium hydroxide- and simeticone-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689317 | Aluminium hydroxide- and magnesium hydroxide- and simeticone-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2689317 | Aluminium hydroxide- and magnesium hydroxide- and simeticone-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2689318 | Aminoacridine hydrochloride 500 microgram/g and lidocaine hydrochloride 6.6 mg/g oromucosal gel | Designated preferred name (PT) | NO | |
| RxCUI: 2689318 | Aminoacridine hydrochloride 500 microgram/g and lidocaine hydrochloride 6.6 mg/g oromucosal gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689318 | Aminoacridine hydrochloride 500 microgram/g and lidocaine hydrochloride 6.6 mg/g oromucosal gel | Full form of descriptor (FN) | NO | |
| RxCUI: 2689319 | Fimasartan potassium trihydrate | Designated preferred name (PT) | NO | |
| RxCUI: 2689319 | Fimasartan potassium trihydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 2689320 | Arterial plasma | Designated preferred name (PT) | NO | |
| RxCUI: 2689320 | Arterial plasma | Full form of descriptor (FN) | NO | |
| RxCUI: 2689321 | sofpironium bromide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2689322 | sofpironium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2689323 | sofpironium 72 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2689324 | sofpironium Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2689325 | sofpironium Topical Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2689326 | sofpironium 12.45 % (72 MG/ACTUAT) Topical Gel Pump, 60 Actuations | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2689326 | sofpironium 12.45 % (72 MG/ACTUAT) Topical Gel Pump, 60 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2689326 | sofpironium 12.45 % (72 MG/ACTUAT) Topical Gel Pump, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2689327 | sofpironium 72 MG/ACTUAT Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2689328 | Sofdra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2689329 | sofpironium 72 MG/ACTUAT [Sofdra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2689330 | Sofdra Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2689331 | sofpironium Topical Gel [Sofdra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2689332 | Sofdra 12.45 % (72 MG/ACTUAT) Topical Gel Pump, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2689332 | Sofdra 12.45 % (72 MG/ACTUAT) Topical Gel Pump, 60 Actuations | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2689332 | Sofdra 12.45 % (72 MG/ACTUAT) Topical Gel Pump, 60 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2689332 | Sofdra 12.45 % (72 MG/ACTUAT) Topical Gel Pump, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2689333 | sofpironium 72 MG/ACTUAT Topical Gel [Sofdra] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689333 | sofpironium 72 MG/ACTUAT Topical Gel [Sofdra] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2689364 | Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689364 | Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689365 | Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689365 | Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689366 | Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil maleate) 245 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689366 | Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil maleate) 245 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689367 | Product containing precisely tenofovir disoproxil (as tenofovir disoproxil phosphate) 245 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2689367 | Product containing precisely tenofovir disoproxil (as tenofovir disoproxil phosphate) 245 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2689368 | Product containing precisely tenofovir disoproxil (as tenofovir disoproxil maleate) 245 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2689368 | Product containing precisely tenofovir disoproxil (as tenofovir disoproxil maleate) 245 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2689777 | Enalapril- and lercanidipine-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2689777 | Enalapril- and lercanidipine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2689779 | Estradiol 1 mg and norethisterone acetate 1 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689779 | Estradiol 1 mg and norethisterone acetate 1 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689779 | Estradiol 1 mg and norethisterone acetate 1 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689780 | Ethinylestradiol beta-cyclodextrin clathrate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689780 | Ethinylestradiol beta-cyclodextrin clathrate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689780 | Ethinylestradiol beta-cyclodextrin clathrate | Designated preferred name (PT) | NO | |
| RxCUI: 2689780 | Ethinylestradiol beta-cyclodextrin clathrate | Full form of descriptor (FN) | NO | |
| RxCUI: 2689781 | 2-propenoic acid, 3-hydroxypropyl ester | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2689785 | methyl salicylate 0.25 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2689786 | camphor 3 % / menthol 10 % / methyl salicylate 25 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2689786 | camphor 3 % / menthol 10 % / methyl salicylate 25 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2689786 | camphor 3 % / menthol 10 % / methyl salicylate 25 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689787 | Amlodipine (as amlodipine besilate) 10 mg and atorvastatin (as atorvastatin calcium) 40 mg and perindopril arginine 10 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689787 | Amlodipine (as amlodipine besilate) 10 mg and atorvastatin (as atorvastatin calcium) 40 mg and perindopril arginine 10 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689787 | Amlodipine (as amlodipine besilate) 10 mg and atorvastatin (as atorvastatin calcium) 40 mg and perindopril arginine 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689788 | petrolatum 820 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2689789 | petrolatum 82 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2689789 | petrolatum 82 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689789 | petrolatum 82 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2689790 | Amlodipine (as amlodipine besilate) 10 mg and indapamide 1.25 mg and perindopril arginine 5 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689790 | Amlodipine (as amlodipine besilate) 10 mg and indapamide 1.25 mg and perindopril arginine 5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689790 | Amlodipine (as amlodipine besilate) 10 mg and indapamide 1.25 mg and perindopril arginine 5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689791 | tolnaftate Medicated Liquid Soap | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2689792 | tolnaftate 1 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2689792 | tolnaftate 1 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689792 | tolnaftate 1 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2689793 | Amlodipine (as amlodipine besilate) 10 mg and perindopril tosilate 10 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689793 | Amlodipine (as amlodipine besilate) 10 mg and perindopril tosilate 10 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689793 | Amlodipine (as amlodipine besilate) 10 mg and perindopril tosilate 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689794 | Amlodipine (as amlodipine besilate) 10 mg and perindopril tosilate 5 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689794 | Amlodipine (as amlodipine besilate) 10 mg and perindopril tosilate 5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689794 | Amlodipine (as amlodipine besilate) 10 mg and perindopril tosilate 5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689796 | Amlodipine (as amlodipine besilate) 5 mg and atorvastatin (as atorvastatin calcium) 10 mg and perindopril arginine 5 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689796 | Amlodipine (as amlodipine besilate) 5 mg and atorvastatin (as atorvastatin calcium) 10 mg and perindopril arginine 5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689796 | Amlodipine (as amlodipine besilate) 5 mg and atorvastatin (as atorvastatin calcium) 10 mg and perindopril arginine 5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689797 | Amlodipine (as amlodipine besilate) 5 mg and atorvastatin (as atorvastatin calcium) 20 mg and perindopril arginine 10 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689797 | Amlodipine (as amlodipine besilate) 5 mg and atorvastatin (as atorvastatin calcium) 20 mg and perindopril arginine 10 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689797 | Amlodipine (as amlodipine besilate) 5 mg and atorvastatin (as atorvastatin calcium) 20 mg and perindopril arginine 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689798 | Amlodipine (as amlodipine besilate) 5 mg and atorvastatin (as atorvastatin calcium) 20 mg and perindopril arginine 5 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689798 | Amlodipine (as amlodipine besilate) 5 mg and atorvastatin (as atorvastatin calcium) 20 mg and perindopril arginine 5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689798 | Amlodipine (as amlodipine besilate) 5 mg and atorvastatin (as atorvastatin calcium) 20 mg and perindopril arginine 5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689799 | Amlodipine (as amlodipine besilate) 5 mg and indapamide 1.25 mg and perindopril arginine 5 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689799 | Amlodipine (as amlodipine besilate) 5 mg and indapamide 1.25 mg and perindopril arginine 5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689799 | Amlodipine (as amlodipine besilate) 5 mg and indapamide 1.25 mg and perindopril arginine 5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689800 | Amlodipine (as amlodipine besilate) 5 mg and indapamide 2.5 mg and perindopril arginine 10 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689800 | Amlodipine (as amlodipine besilate) 5 mg and indapamide 2.5 mg and perindopril arginine 10 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689800 | Amlodipine (as amlodipine besilate) 5 mg and indapamide 2.5 mg and perindopril arginine 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689801 | Amlodipine (as amlodipine besilate) 5 mg and perindopril tosilate 10 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689801 | Amlodipine (as amlodipine besilate) 5 mg and perindopril tosilate 10 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689801 | Amlodipine (as amlodipine besilate) 5 mg and perindopril tosilate 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689802 | Amlodipine (as amlodipine besilate) 5 mg and perindopril tosilate 5 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689802 | Amlodipine (as amlodipine besilate) 5 mg and perindopril tosilate 5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689802 | Amlodipine (as amlodipine besilate) 5 mg and perindopril tosilate 5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689804 | Amlodipine (as amlodipine besilate) 5 mg and valsartan 80 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689804 | Amlodipine (as amlodipine besilate) 5 mg and valsartan 80 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689804 | Amlodipine (as amlodipine besilate) 5 mg and valsartan 80 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689806 | Brinzolamide 10 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops suspension | Designated preferred name (PT) | NO | |
| RxCUI: 2689806 | Brinzolamide 10 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 2689808 | Brinzolamide- and timolol-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2689808 | Brinzolamide- and timolol-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2689809 | Brinzolamide- and timolol-containing product in ocular dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2689809 | Brinzolamide- and timolol-containing product in ocular dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2689812 | Fluorouracil 5 mg/g and salicylic acid 100 mg/g cutaneous solution | Designated preferred name (PT) | NO | |
| RxCUI: 2689812 | Fluorouracil 5 mg/g and salicylic acid 100 mg/g cutaneous solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2689814 | Aminoacridine- and lidocaine-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2689814 | Aminoacridine- and lidocaine-containing product in oromucosal dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689814 | Aminoacridine- and lidocaine-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2689815 | Benzydamine hydrochloride 1.5 mg/mL and cetylpyridinium chloride 5 mg/mL oromucosal solution | Designated preferred name (PT) | NO | |
| RxCUI: 2689815 | Benzydamine hydrochloride 1.5 mg/mL and cetylpyridinium chloride 5 mg/mL oromucosal solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2689816 | Benzydamine- and cetylpyridinium-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2689816 | Benzydamine- and cetylpyridinium-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2689818 | Dapagliflozin (as dapagliflozin propanediol) 5 mg and metformin hydrochloride 1 g oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689818 | Dapagliflozin (as dapagliflozin propanediol) 5 mg and metformin hydrochloride 1 g oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689819 | Dapagliflozin (as dapagliflozin propanediol) 5 mg and metformin hydrochloride 850 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2689819 | Dapagliflozin (as dapagliflozin propanediol) 5 mg and metformin hydrochloride 850 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2689820 | Foscarbidopa- and foslevodopa-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2689820 | Foscarbidopa- and foslevodopa-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2689821 | Foscarbidopa-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2689821 | Foscarbidopa-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2689822 | Amlodipine- and indapamide- and perindopril-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2689822 | Amlodipine- and indapamide- and perindopril-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2689823 | Amylmetacresol 290 microgram and dichlorobenzyl alcohol 580 microgram and lidocaine 780 microgram/actuation oromucosal spray | Designated preferred name (PT) | NO | |
| RxCUI: 2689823 | Amylmetacresol 290 microgram and dichlorobenzyl alcohol 580 microgram and lidocaine 780 microgram/actuation oromucosal spray | Full form of descriptor (FN) | NO | |
| RxCUI: 2689824 | Amylmetacresol- and dichlorobenzyl alcohol- and lidocaine-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2689824 | Amylmetacresol- and dichlorobenzyl alcohol- and lidocaine-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2689825 | Amylmetacresol- and dichlorobenzyl alcohol- and lidocaine-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2689825 | Amylmetacresol- and dichlorobenzyl alcohol- and lidocaine-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2689831 | Pseudocereal grain | Designated preferred name (PT) | NO | |
| RxCUI: 2689831 | Pseudocereal grain | Full form of descriptor (FN) | NO | |
| RxCUI: 2689833 | Antibody to Retroviridae | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689833 | Antibody to Retroviridae | Full form of descriptor (FN) | NO | |
| RxCUI: 2689833 | Antibody to Retroviridae | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689833 | Antibody to Retroviridae | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689833 | Antibody to Retroviridae | Designated preferred name (PT) | NO | |
| RxCUI: 2689834 | Antibody to Rickettsiales | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689834 | Antibody to Rickettsiales | Full form of descriptor (FN) | NO | |
| RxCUI: 2689834 | Antibody to Rickettsiales | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689834 | Antibody to Rickettsiales | Designated preferred name (PT) | NO | |
| RxCUI: 2689835 | Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for infusion and/or injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2689835 | Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for infusion and/or injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 26899 | HDL1 - high density lipoprotein subfraction 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26899 | HDL1 - high density lipoprotein subfraction 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26899 | HDL1 - high density lipoprotein subfraction 1 | Designated preferred name (PT) | NO | |
| RxCUI: 26899 | HDL1 - high density lipoprotein subfraction 1 | Full form of descriptor (FN) | NO | |
| RxCUI: 2689922 | Modulis | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2689923 | cyclosporine, modified 100 MG/ML [Modulis] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2689923 | cyclosporine, modified 100 MG/ML [Modulis] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2689924 | Modulis Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2689925 | Modulis Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2689926 | cyclosporine Oral Solution [Modulis] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2689926 | cyclosporine Oral Solution [Modulis] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2689927 | cyclosporine, modified Oral Solution [Modulis] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2689928 | Modulis 100 MG/mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2689928 | Modulis 100 MG/mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2689928 | Modulis 100 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2689928 | Modulis 100 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2689929 | bis(cysteinyl maleimide) PEG 20000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
